Autism spectrum disorder (ASD) is a neurodevelopmental disease characterized by repetitive behaviors and a lack of social communication. The role of probiotics, phytochemicals and their combination phytochemicals as treatment options for ASD is still under study.
Objective
This study aimed to evaluate the associated molecular pathways and explore the impact of Lactobacillus rhamnosus (L. rhamnosus), thymol (Thy) and their combination on propionic acid (PA)-induced ASD rats.
Methods
Fifty 3-week-old male albino rat pups were randomly distributed into five groups. The groups included a control group, a PA-induced ASD group, in which PA (250 mg/kg, p.o.) was administered for 3 days, and three other groups that received PA (250 mg/kg, p.o.) for 3 days along with either L. rhamnosus (1 × 10^6 CFU/day, p.o), Thy (30 mg/kg/day, p.o), or both. Brain tissues were collected for biochemical, histological, and immunohistochemical studies following behavioral evaluations.
Results
Compared with the group administered only PA, treatment with L. rhamnosus, Thy and their combination significantly improved the neurobehavioral deficits in the autistic group. Improvements were observed in tests assessing memory consolidation, learning capacity, attention, spatial memory, locomotor activity, and contextual information processing. In addition to histopathological improvements, L. rhamnosus, Thy and their combination demonstrated notable ameliorative effects on PA-induced abnormalities in brain neurotransmitters, oxidative stress, inflammation, apoptosis, and endoplasmic reticulum (ER) stress and autophagy biomarkers. Furthermore, treatment with L. rhamnosus, Thy and their combination improved abnormalities in the tested biomarkers and modulated associated pathways, including significant upregulation of BDNF, TrkB, CREB, Nrf2, and HO-1 content and downregulation of TLR4/NF-κB-mediated neuroinflammation, leading to substantial improvements in ASD symptoms.
Conclusion
Our results suggest that L. rhamnosus, Thy and their combination have promising therapeutic potentials in alleviating biochemical and behavioral deficits in PA-induced autism. These effects may be mediated by halting apoptosis, inflammation, and endoplasmic reticulum stress, inducing autophagy, and improving different biomarkers and modulation pathways, such as Wnt3/β-catenin/GSK3β, pI3K/p-Akt/mTOR, and BDNF/p-TrkB/CREB.
Graphical Abstract
L. rhamnosus is Lactobacillus rhamnosus.
Flowchart illustrating the effects of L. rhamnosus, Thymol, or both on neurological functions. It details behavioral tests and biochemical analyses on propionic acid's effects, such as impaired neurotransmission and neurodevelopmental deficits. Key areas include apoptosis, autophagy, neuroinflammation, and oxidative stress, with specific protein markers indicated for each process.
autismautophagyendoplasmic reticulum stressoxidative stressprobioticsthymolThe author(s) declared that financial support was received for this work and/or its publication. The authors extend their appreciation to the Deanship of Research and Graduate Studies at the University of Tabuk for funding this work through research number “0088-S-2024.”section-at-acceptanceNeuropharmacologyIntroduction
The neurological disorder known as autism spectrum disorder (ASD) affects behavior, communication, and social relationships (Altomi et al., 2025). It has been proven that people with ASD have abnormal neurodevelopmental pathways that diverge from the normal patterns of brain development. The complex interaction of genetic factors, environmental effects, epigenetic mechanisms, cognitive processes, and behavioral components in ASD causes a wide range of symptoms and comorbid problems (Liloia et al., 2024).
Both genetic and non-genetic variables are probably involved in the complex etiology of ASD (Taylor et al., 2020; Sztainberg and Zoghbi, 2016; Sauer et al., 2021). Approximately 1% of people worldwide have ASD, with a higher male-to-female ratio (4:1) (Altomi et al., 2025). In addition to having intellectual disabilities, approximately 50% of people with ASD also frequently suffer from co-occurring neurodevelopmental and psychiatric disorders (Khogeer et al., 2022).
Oxidative stress and neuroinflammation are acknowledged as key factors influencing the development of ASD (Usui et al., 2023; Za et al., 2021). These processes frequently result in behavioral deficiencies, decreased neuroplasticity, and brain damage—all of which are characteristics of the pathophysiology of ASD. People with ASD frequently experience oxidative stress, which is caused by an excess of reactive oxygen species (ROS). Lipid and mitochondrial malfunction and an increase in malondialdehyde (MDA), a crucial indicator of oxidative damage, have all been linked to this imbalance in oxidative homeostasis. As demonstrated by increased pro-inflammatory cytokines such as prostaglandin E2 (PGE2), interleukin (IL)-6, IL-17, and tumor necrosis factor (TNF)-α, the ensuing oxidative stress may be a contributing factor to chronic neuroinflammation (Kılıç et al., 2025). Neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), which are essential for synaptic plasticity and neuronal survival, are also downregulated by these inflammatory mediators (Kerschensteiner et al., 1999; Lai et al., 2018).
Numerous related proteins, including neurotransmitter transporters and receptors, are typically implicated in the clinical manifestation of various neurological conditions, including ASD. Deficits in ASD are linked to glutamate (Glu), dopamine (DA), serotonin (5-HT), and glutamate/GABA imbalance in the brain tissues (Bin-Khattaf et al., 2022; Quaak et al., 2013). Autophagy-related genes have exonic copy number variation mutations linked to ASD (Poultney et al., 2013). So, it is suggested that autophagy failure is a contributing factor to ASD. Through the IGF-1/PI3K/AKT/mTOR pathway, mammalian target of rapamycin (mTOR), a master regulator of cell proliferation, cellular metabolism, and autophagy, has been implicated in the development of ASD (Bozdagi et al., 2013; Zhang et al., 2020). In this scenario, it was suggested that autophagy is widely regulated through the PI3K/AKT/mTOR pathway, which will impact the development of ASD (Zhang et al., 2016). Moreover, it is reported that ASD progeny exhibited aberrant behavior that might have been caused by prolonged ER stress (Kawada and Mimori, 2018). Apoptosis, or programmed cell death, is a crucial process that controls the appropriate wiring of developing neural networks and shapes the brain’s size and structure. Neuroanatomic defects and developmental impairments can result from aberrant stimulation of apoptotic death mechanisms. Neural cell death has been shown to have a potential correlation with autism (Kılıç et al., 2025).
In order to simulate and investigate the pathogenic mechanisms underlying behavioral impairments and facilitate the search for a cure, animal models were developed. Chemical and genetic models are the two primary categories of animal models (Ali et al., 2022). The effectiveness of the chemical model depends on whether the substances utilized have the same effects on people. Propionic acid (PA) is a short-chain fatty acid that is formed regularly as a by-product of the metabolism of carbohydrates and certain sugars. It is detected in high concentrations in the blood, urine, and facial samples of autistic people (Choi et al., 2018; Cotrina et al., 2020) and is implicated in neurochemical autism. PA has been demonstrated to have a wide range of functions in host cellular physiology in both health and disease. Moreover, PA plays a vital role in immunity, metabolism, and development under healthy conditions, but it also impacts behavior and brain function in certain hereditary and acquired illnesses (Ma et al., 2011; Nankova et al., 2014; Abdelli et al., 2019). PA is a weak acid that is systematically absorbed by the gut, liver, and brain through passive and active monocarboxylate transporters. It also activates G-protein-coupled receptors (Ma et al., 2011). Developmental delay, oxidative stress, and metabolic or immunological abnormalities are associated with elevated PA levels; these symptoms share some parallels with those of propionic acidemia and autism (Cotrina et al., 2020; Ma et al., 2011; Nankova et al., 2014). Bacteria that produce PA, such as Bacteroidetes, Clostridium, and Desulfovibrio, are commonly found in high concentrations in the stomachs of people with ASD. In addition, PA is also frequently added to processed meals that contain carbohydrates, which many children with ASD consume (Thomas et al., 2012). This, in addition to gastric absorption, causes the gut microbiota to produce more of this acid (Ma et al., 2011).
The administration of PA has been found to prompt disruption, neuroinflammation, and oxidative stress of synaptic plasticity pathways, which is presented by a significant elevation of NF-kB, TNF-α, and MDA, a significant reduction in NRF2, CAT, SOD, and BDNF levels, and disruption of the Wnt/β-catenin pathway, making it an appropriate model to study autism and therapies that affect these mechanisms (He et al., 2018; Sahin et al., 2022).
In addition to its antibacterial, antioxidant, anticancer, anti-inflammatory, and antitussive properties, Thy is a naturally occurring phenolic monoterpene derivative of the umbelliferous hydrocarbon and carvacrol tautomer (Xiong et al., 2023). Additionally, Thy is a volatile oil with several benefits: low molecular weight, easy blood–brain barrier crossing, high volatility, and suitability for treating brain problems (Zhang et al., 2021). Thy has demonstrated effectiveness in blocking a variety of inflammatory indicators, including cyclooxygenase-2; interleukins IL-1β, IL-6, and IL-8; and tumor necrosis factor-alpha (TNF-α). Its ability to disrupt the NF-κB and MAPK pathways, which are key modulators of inflammatory gene expression, is primarily responsible for these effects. These molecular processes highlight the capacity of Thy to function in several clinical situations where either acute or chronic inflammation is important (Gago et al., 2025). Furthermore, Thy protects rats against monosodium glutamate-induced attention-deficit/hyperactivity disorder-like behavior (Abu-Elfotuh et al., 2022a). In the depression model of chronic unexpected mild stress, Thy may control the expression of TNF-a and IL-1β (Deng et al., 2015). The positive benefits observed after Thy therapy are largely due to the p38 MAPK pathway (Shu et al., 2016). These results show that Thy might control inflammation through the Pin1/p38 MAPK pathway in rats with ASD (Xiong et al., 2023).
L. rhamnosus is found in the native microbiota and is beneficial for health because it can reduce oxidative stress and possesses anti-inflammatory properties. It can also restore the gastrointestinal barrier function, alter the levels of several neurotransmitters and cytokines, and modulate different signaling pathways (Alsubaiei et al., 2022). Additionally, the primary metabolites of the microbiome, short-chain fatty acids (SCFAs), which are generated by bacterial fermentation, might influence the microbiome–gut–brain axis either directly or indirectly. The dosage of these metabolites may also be crucial in determining how they alter the behavioral and psychophysiological processes (Martin et al., 1984). Moreover, L. rhamnosus, which produces GABA, may be a suitable candidate to alter the glutamate/GABA ratio, making it a potentially effective treatment for social behavioral symptoms linked to ASD (Patel et al., 2020; Saber et al., 2021).
However, the role of probiotics and/or phytochemicals through the gut–microbiota–brain axis as treatment options is still under study. In this study, we hypothesized that L. rhamnosus, Thy and their combination would ameliorate PA-induced neurobehavioral deficits by modulating oxidative stress, neuroinflammation, and apoptosis and restoring key neurodevelopmental and synaptic plasticity pathways, and we analyzed our theory by testing behavioral and histopathological changes and the levels of specific biological markers.
Materials and methodsDrugs and dosage
Thymol (Thy) and all other chemicals used (analytical grade) were purchased from Sigma-Aldrich Chemical Co. (CAS No.: 89-83–8, St. Louis, MO., United States).
Bacterial strain and culture conditions
A standard strain of L. rhamnosus (ATCC 7469) was used in this study. It was cultured in 100 mL of liquid de Man, Rogosa, and Sharpe (MRS; OXOID Ltd., United Kingdom) agar (Oxoid, England) and broth media in a shaker incubator set to 200 rpm at 37 °C for 24 h under aerobic conditions (Zhang et al., 2020). A suspension of L. rhamnosus (1 × 106 CFU) was prepared in sterile saline for feeding the rats. Briefly, a saline solution (0.9% sodium chloride) was used to resuspend the sediments. We combined the L. rhamnosus suspensions and added the physiological saline solution until the final amount was 10 mL. This mixture was prepared daily and used immediately. We periodically examined the sediment for the quantity and type of microorganisms before mixing it. We employed the double dilution approach and MALDI-TOF in this verification procedure (Zhang et al., 2016).
Animals
Male 3-week-old albino rat pups (n = 50) that were newly born and weighed between 25 and 30 g were used in the study. The animals were housed in controlled environments with a constant temperature of 24 ±1 °C and a light/dark cycle of 12/12 h. Rats were kept in stainless steel cages in a hygienic animal room under a regular light–dark cycle at 26 °C ± 4 °C. All animal procedures were carried out as previously described (Abu-Elfotuh et al., 2023). Briefly, rats were provided with standardized AIN-93 Purified Rat Diets (El-Nasr Company, Abu Zaabal, Cairo, Egypt) and water ad libitum.
Ethical consideration and approval
The NIH Guideline for the Care and Use of Laboratory Animals (NIH Publications No. 85–23, updated 2011) was followed. Moreover, all animal handling procedures were overseen by the Animal Ethics Committee of the Faculty of Pharmacy (Girls), Al-Azhar University, Egypt (No.384/2023). Every effort was made to minimize the suffering experienced by the animals throughout the trial.
Induction of autism spectrum disorder in rats
The rats were given freshly prepared PA (250 mg/kg) in double-distilled water orally via an intragastric tube for 3 days and were then administered daily oral saline for the remaining 27 days (until the end of the study period) (Alsubaiei et al., 2022).
Design of experiments
Following weaning, rat pups were randomly assigned to one of five groups (n = 10/group) using a computer-generated random number sequence. Each animal was given a temporary cage number. After assigning each rat to an experimental group, the temporary numbers were replaced with permanent, distinct, sequential, identification numbers. All animals were weighed and checked for clinical abnormalities by expert technicians on the final day of the quarantine period in order to exclude those deemed unsuitable for research. The animal weights offer the day 0 data and are an essential component of the randomization procedure. A suitable data gathering method was used to insert body weights and temporary cage numbers straight into a file or from paper tape or computer cards (Martin et al., 1984).
Based on standard procedures in comparable preclinical behavioral and biochemical studies using this model, a sample size of n = 10 per group was chosen to ensure sufficient statistical power to detect significant effect sizes. To guarantee an impartial distribution of litter effects across all groups, rat pups were randomly assigned to one of the five experimental groups (n = 10 per group) after the weaning period using a computer-generated random number sequence.
Fifty 3-week-old male albino rat pups were randomly divided into five groups.
The following groupings were allocated from the animals, with 10 animals in each group.
Group 1: control group; rats were given oral normal saline every day for 4 weeks.
Group 2: the autistic group; rats were given oral PA (250 mg/kg) for 3 days, followed by daily oral saline for the remaining 27 days.
Group 3: the PA + L. rhamnosus group; rats were given oral PA (250 mg/kg) for 3 days and then L. rhamnosus suspension (1 × 10^6 CFU/day) (Patel et al., 2020) orally for the remaining 27 days (Alsubaiei et al., 2022).
Group 4: the PA + Thy group; rats were given oral PA (250 mg/kg) for 3 days and then oral Thy (30 mg/kg/day) (Saber et al., 2021) every day for the remaining 27 days.
Group 5: the PA + L. rhamnosus + Thy group; rats were given oral PA (250 mg/kg) for 3 days and then both L. rhamnosus suspension (1 × 10^6 CFU/day) and Thy (30 mg/kg/day) by oral gavage (Nagoor Meeran et al., 2017) every day for the remaining 27 days (Abu-Elfotuh et al., 2023; Saber et al., 2021).
Experiment timeline
Fifty male rat pups (3 weeks old) were split into five groups at random (n = 10). During the PA-induction phase, PA (250 mg/kg) was administered orally for 3 days in a row. Following this, groups were given daily oral dosages of saline accompanied with either L. rhamnosus (1x10^6 CFU), Thy (30 mg/kg), or their combination for a duration of 27 days. Saline was administered to the control group for the full period of 30 days. Following behavioral testing at the conclusion of the treatment period, brain tissues were obtained for immunohistochemical, molecular, and biochemical investigation.
All behavioral testing, biochemical tests, and histological/histopathological evaluations were carried out by expert technicians who were blinded to the animal and sample treatment group assignments in order to reduce bias.
Behavioral studies
After the end of the 30-day period (from the start to the end of the end of the experiments), the animals were transferred to the behavioral laboratory for a 1 -hour acclimation period before the start of behavioral testing, without access to food or water. Experiments were carried out at a fixed time between 9 a.m. and 2 p.m.
Open-field test
The device used in these experiments was a wooden box that was square-shaped and had white flooring and crimson walls. The floor was separated into two sections, each measuring 80 cm in length and 40 cm in height, and divided into 16 identical 20 cm × 20 cm square sections (Ali et al., 2017). Each rat was positioned in the middle of the device. By tracking the latency time(s), which is the amount of time between dropping an animal and its choice to move, and the ambulation frequency, which is the number of crossed squares over a 3-min period, the behavioral parameters for locomotor activity were assessed (Isaev et al., 2020).
Y-maze test
According to Hughes et al.’s experiment (Aspide et al., 1998), the Y-maze used was a wooden, black maze consisting of three equal-sized arms, designated A, B, and C. Each arm measured 12 cm in width, 40 cm in length, and 35 cm in height and was positioned at 120° away from the other two arms (Hughes, 2004). For 8 minutes, rats were placed at the end of one arm and given complete freedom to move throughout the maze. Entry into all three arms on consecutive choices was defined as spontaneous alternation behavior (SAB). SAB is a reflection of both attention and spatial memory (Aspide et al., 1998). The following formula was used to determine the percentage of spontaneous alternation: (number of alternations/total arm entries) X 100 = spontaneous alternation.
Forced swimming test
The forced swimming test (FST) assesses the effectiveness of potential antidepressant medications (Teixeira et al., 2013). FST was conducted in a plexiglass cylinder that measured 30 cm in diameter and 45 cm in height. To keep a rat’s paw from reaching the plexiglass floor, the water was just 25 cm deep. Training and testing were applied to the two phases of this experiment. During the training phase, each rat spent 15 minutes in a swimming pool. The last 5 minutes were used to record the rat’s activity.
The amount of time that each rat is movable is recorded during the behavioral analysis. The immobility time is then calculated by deducting the overall mobility time from the 240 s of the test time.
Each rat was submerged in the water four times, and the data gathered corresponded with the training phase. Increased immobility time is interpreted as a depressive-like behavior (Can et al., 2012; Carlezon et al., 2002).
Conditioned avoidance response test
The conditioned avoidance response (CAR) test is used to evaluate memory consolidation and learning capacity under extreme stress (Castagné et al., 2009). For this test, a wooden box apparatus measuring 43.3 × 11.8 × 15.8 inches was utilized. The box has moveable glass panels that separate it into five connected rooms. A stimulator set to 50 V and 25 pulses per second electrified the four rooms’ flooring, which was composed of a grid of parallel metal rods. The sixth chamber’s floor was composed of glass.
A day before testing, the experimental animals were trained. Five seconds of auditory stimuli (a conditioned stimulus) were paired with 5 seconds of foot shock to conduct the training. For 2 days, the same animals underwent repeated testing. The number of trials [on the first and second day] after treatment that each rat needed to complete in order to reach the safe region (and avoid the electric shock) during the 5 seconds of the conditioned stimulus prior to the electric shock being administered was determined.
Rats were weighed at the end of the experiments; following that, pentobarbital (50 mg/kg) was used to euthanize the rats, and the animals were terminated by cervical dislocation. After that, the brains were dissected right away, cleaned with ice-cold saline (0.9 percent w/v), and cut into three parts. The first portion was immediately frozen on ice and kept at −80 °C until it was used for polymerase chain reaction (PCR) analysis to evaluate gene expression. The second part was kept at −20 °C until it was utilized for biochemical studies. The third component was stored in the proper buffer until it was used for histopathological analysis (Abu-Elfotuh et al., 2022a).
The following biomarkers were assessed in 10% brain supernatant using rat-specific enzyme-linked immunosorbent assay (ELISA) kits and following the manufacturer’s instructions: the proteins include apoptosis-inducing factor (AIF), TNF-α, interleukin (IL)-1β, gamma-aminobutyric acid (GABA), dopamine (DA), Wingless-type MMTV Integration Site Family (Wnt3), β-catenin, glycogen synthase kinase-3 beta (GSK3β) (MyBioSource, Inc., San Diego, CA, United States, Cat # MBS163437, MBS175904, MBS2023030 MBS269152, MBS701755, MBS2025504, MBS261324, and MBS766198, respectively), and noradrenaline (NA) (Cusabio Technology, China, Cat. No. CSB-E07870m).
Colorimetric assays
Using commercial colorimetric assay kits supplied by Bio Diagnostics, Inc., Giza, Egypt, a 10% brain supernatant was colorimetrically examined for total antioxidant capacity (TOC) and malondialdehyde (MDA).
Gene expression measurement by quantitative real-time PCR analysis
Using quantitative real-time PCR (qPCR) analysis to quantify gene expression using Applied Biosystems StepOnePlus technology and qPCR, the research biomarkers and the housekeeping gene β-actin mRNA levels in the brain tissue were evaluated. First, the total RNA was extracted using a QIAGEN Tissue Extraction Kit®. A SensiFAST cDNA Synthesis Kit® (Cat. # BIO- 65053) was then used to reverse-transcribe the isolated mRNA (Alsubaiei et al., 2022). Primers for DNA amplification, QIAGEN® DNA Master Mix, and real-time qPCR SYBR Green® were used. Software version 3.1 (StepOneTM, United States) from Applied Biosystems® was used to evaluate the data in relation to the housekeeping gene, β-actin. Table 1 displays the primer sequences. All experiments were carried out in triplicate. The primers were produced by Shanghai Jierui Biological Engineering Co., LTD., after being chosen from the PubMed database. The relative gene expression (2−ΔΔCT) method was used to assess the RT-PCR data (Abu-Elfotuh et al., 2022a).
Primer sequences utilized in the qPCR analysis of rat brain tissues.
Gene
Forward primer
Reverse primer
GenBank accession number
AIFAKT1AMPKBaxBeclin-1Bcl2caspase-1CREB1CHOPGRP78H O -1mTORNF-κBNLRP3Nrf2PERKpI3KTrkBSIRT1TLR4β-actin
Brain tissue specimens were preserved in buffered neutral formalin (10%) for histopathological analyses. After being dehydrated, hippocampal specimens were sectioned (4 µm–5 µm) and embedded in paraffin. Hematoxylin and eosin (H&E) were used to stain the sections, which were then analyzed using a Nikon Eclipse E200-LED microscope (Tokyo, Japan, ×200 and ×400 magnification). A semi-quantitative scoring system was used to characterize the extent of hippocampal damage (degree of nuclear pyknosis and degeneration and brain tissue lesions). Five grades were assigned based on the degree of injury: 1, minimal injury (<1%); 2, slight injury (1%–25%); 3, moderate injury (26%–50%); 4, moderate/severe injury (51%–75%); and 5, severe injury (76%–100%) (Nakaji et al., 2002).
Brain tissue sections were treated with an anti-glial fibrillary acidic protein (anti-GFAP) antibody (1:800 dilution; Servicebio, United States, Cat# GB12090) at 4 °C for a whole night in order to detect glial fibrillary acidic protein (GFAP). This was followed by a 1-h incubation with a biotinylated secondary antibody at room temperature. Brown precipitate was developed using the 3,3-diaminobenzidine peroxidase substrate kit. A Nikon Eclipse E200 LED (Tokyo, Japan) was used to view the photos at a magnification of ×400 (Albrakati et al., 2021).
Analysis of statistics
Data were expressed as the mean +S.E.M., and statistical analysis was carried out using one-way ANOVA followed by Tukey’s multiple comparisons test to determine the significance of differences between treatments. Values of p < 0.05 were considered significant. All statistical analyses were performed, and graphs were sketched using GraphPad Prism (ISI, United States) software (version 6).
Results
In this work, the actions of L. rhamnosus and/or thy on normal control groups were studied; however, these three groups showed no significant differences from the normal control group in all the measured biochemical parameters or in the histopathological findings. Consequently, the actions of L. rhamnosus, Thy and their combination on normal rats are not shown in order to avoid the complexity of data.
Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the behavioral changes detected in PA-induced neurotoxicity
In the Y-maze test, an indication of spatial working memory and cognitive function, administration of PA significantly reduced SAP% by 49.2% compared to that in normal control rats (Figure 1A). Treatment with L. rhamnosus, Thy and their combination significantly increased SAP% by 26.8%, 35%, and 43%, respectively, compared to that in the PA group. In the same way, in the open-field test, an indication for the locomotor activity and anxiety-like behaviors showed that administration of PA caused disarray in decision-making by significantly prolonging the latency score to approximately 10.6 times, decreasing the attentive processes, ambulation, and rearing frequencies that underlie the gathering of contextual information in novel situations, as evidenced by a significant decrease in rearing frequency to 25.7% and decreasing locomotor activity to 50% compared to those in the control group.
Therapeutic effects of L. rhamnosus, Thy and their combination on the behavioral changes detected in PA-induced neurotoxicity; Y-maze test: (A) SAP (%); OFT tests: (B) latency duration, (C) ambulation frequency, and (D) rearing frequency. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to PA + Lactobacillus rhamnosus. (d) Significance relative to PA + Thy. PA, propionic acid, OFT, open-field test, SAP, spontaneous alternation performance. The mean ± SEM was used to establish the results (n = 6). One way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Four bar charts labeled A, B, C, and D compare different treatments: Control, PA, PA + Lactobacillus, PA + Thymol, and PA + COMB. Chart A shows Y maze-SAP percentage; Chart B shows OFT latency in seconds; Chart C shows OFT ambulation frequency; and Chart D shows OFT rearing frequency. Each chart displays significant differences using letters “a, b, c, d” above bars, indicating statistical analysis results.
These behavioral changes were considerably lessened upon treatment with L. rhamnosus (32.6% decrease and 3-fold and 1.5-fold increase for the latency score, rearing, and ambulation frequencies, respectively); with Thy (21.7% decrease and 3.1-fold and 1.5-fold increase for the latency score, rearing, and ambulation frequencies, respectively); and with both L. rhamnosus and Thy (18% decrease and 3.5-fold and 1.7-fold increase for the latency score, rearing, and ambulation frequencies, respectively) compared to that in the PA group. Interestingly, the measured behavioral parameters returned to their normal values through co-administration of both L. rhamnosus and Thy (Figures 1B–D).
More detailed values of the results are illustrated in Supplementary Tables 1–4.
In the FST behavioral tests, for the swimming score (Figure 2A), the PA group showed a significant reduction of 83.3% compared to the control group. Meanwhile, administration of L. rhamnosus, Thy, or their combination showed significantly increased swimming scores by 4.1, 4.2, and 4.9 times, respectively, compared to that in the PA group. Interestingly, the L. rhamnosus and Thy combination group showed no significant difference in the swimming score compared to that in the control group. In the same way, administration of PA considerably increased the immobility score by 9.5 times compared to that in the control group. Meanwhile, the immobility scores of rats improved significantly with the administration of L. rhamnosus, Thy, or their combination compared to those in the PA group (Figure 2B). Interestingly, the L. rhamnosus and Thy combination group had the highest efficacy, returning the scores to the normal level without a significant difference compared to those in the control group.
Therapeutic effects of L. rhamnosus, Thy and their combination on behavioral changes induced by PA-related neurotoxicity. (A) Swimming, (B) immobility in the FST, and performance in the CAR behavioral test. (C) No. of trails to avoid electric shock in the 1st day. (D) No. of trails to avoid electric shock in the 2nd day. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid. The mean ± SEM was used to establish the results (n = 6). One way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs A, B, C, and D show the effects of different treatments on swimming score, immobility score, and avoidance trials. Graph A shows swimming scores highest in Control, lowest in PA. Graph B shows immobility scores highest in PA. Graphs C and D demonstrate trials to avoid electric shock, with PA showing the most trials initially, decreasing on the second day. Different treatments include PA, PA combined with Lactobacillus, Thymol, or COMB, each impacting scores variably. Statistical annotations (a, b, c, d) indicate significance levels across comparisons.
Concerning the conditioned avoidance response test (CAR), compared to the control group, the PA group showed an increase in the avoidance response number to the electric shock by 7.7 times on the first day (Figure 2C) and 6.5 times on the second day (Figure 2D). The difference between the two groups was statistically significant on both the first and second days. The number of trials for electric shock avoidance response decreased by approximately 58.3%, 60.9%, and 74%, respectively, on the first day and by approximately 61.5%, 69.2%, and 73.8%, respectively, on the second day after treatment with L. rhamnosus, Thy, or their combination compared to that in the PA group. Interestingly, in the same way, the L. rhamnosus and Thy combination group still had the highest efficacy for the electric shock avoidance response, returning the scores to the normal level without a significant difference compared to that in the control group.
Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral levels of neurotransmitters in PA-induced neurotoxicity
Figure 3 demonstrates that compared to those in the control group, the cerebral levels of DA, NE, 5-HT, and GABA in the PA group were significantly lowered by 67.9%, 44.5%, 60.7%, and 73%, respectively. However, compared to that in the PA group, administration of L. rhamnosus resulted in a significant increase in DA, NE, 5-HT, and GABA levels by 1.5, 1.2, 1.6, and 1.4 times, respectively. Furthermore, compared to those in the PA group, Thy significantly increased the DA, NE, 5-HT, and GABA levels by 1.9, 1.3, 1.9, and 1.4 times, respectively. Co-administration of L. rhamnosus and Thy showed significantly greater increases in cerebral DA, NE, 5-HT, and GABA levels by 2.2-fold, 1.6-fold, 2.2-fold, and 1.5-fold, respectively.
Therapeutic effects of Lactobacillus rhamnosus, Thy and their combination on the cerebral levels of neurotransmitters in PA-induced neurotoxicity. (A) 5-HT, (B) NE, (C) DA, and (D) GABA in autistic rats. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid. 5-HT, serotonin; NE, norepinephrine; DA, dopamine; GABA, gamma-aminobutyric acid. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs labeled A to D display biochemical measures across different treatments. A: 5-HT levels (ng/g tissue) are highest in PA + COMB and lowest in PA. B: NE levels (nmol/g tissue) increase similarly, with the lowest in PA. C: DA levels (ng/g tissue) follow this pattern. D: GABA levels (μg/g wet tissue) are also higher in PA + Thymol and PA + COMB, with the lowest in PA. Each treatment group shows significant variation labeled with "a, b, c, d".Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral levels of neuroinflammatory biomarkers in PA-induced neurotoxicity
As shown in Figure 4, compared to that in the control group, PA significantly elevated the cerebral inflammatory biomarkers TLR4, TNF-α, IL-1β, NF-κβ, and NLRP3 by 9.4, 3.6, 4.2, 9.6, and 9.8 times, respectively. On the other hand, treatment with L. rhamnosus led to a significant decrease in the cerebral levels of TLR4, TNF-α, IL-1β, NF-κβ, and NLRP3 by 37.5%, 21.9%, 20.4%, 38.2%, and 29.7%, respectively, compared to that in the PA group. In parallel, compared to that in the PA group, administration of Thy reduced the cerebral levels of TLR4, TNF-α, IL-1β, NF-κβ, and NLRP3 by 52.5%, 44.3%, 51.8%, 49.2%, and 46%, respectively. Remarkably, compared to that in the untreated PA group, co-administration of L. rhamnosus and Thy had the highest inhibitory effects on the cerebral levels of TLR4, TNF-α, IL-1β, NF-κβ, and NLRP3 by 65.3%, 52.9%, 61.6%, 67.5%, and 61.9%, respectively (Figure 4).
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral levels of neuroinflammatory biomarkers in PA-induced neurotoxicity. (A) TLR-4, (B) TNF-α, (C) IL-1β, (D) NF-κB, and (E) NLRP3. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid. TLR-4, Toll-like receptor-4; TNF-α, tumor necrosis factor alpha; IL-1β, interleukin-1β; NF-κB: nuclear factor kappa B; NLRP3, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3. The mean ± SEM was used to establish the results (n = 6). One way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs labeled A to E displaying various gene expressions and protein levels. A: TLR4 relative gene expression across five groups, highest being "PA" and lowest "Control." B: TNF-alpha levels, highest in "PA," with significant differences noted. C: IL-1beta levels, highest in "PA" group. D: NF-kappa B relative expression, "PA" is highest. E: NLRP3 relative gene expression, "PA" also shows the highest level. Statistical significance indicated with letters above bars.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral levels of oxidative stress biomarkers in PA-induced neurotoxicity
As shown in Figure 5, administration of PA significantly increased the cerebral level of MDA in the brain by 7.9 times and drastically reduced the amounts of antioxidants TAC, SOD, HO-1, and Nrf2 by 75.9%, 80.9%, 69%, and 75.9%, respectively, compared to that in the control group. Compared to that in the PA group, treatment with L. rhamnosus resulted in a 23.4% decrease in the content of MDA in the brain but a 1.9-, 1.7-, 1.6-, and 2.6-fold increase in TAC, SOD, HO-1, and Nrf2 levels, respectively. In the same way, compared to that in the PA group, treatment with Thy showed a significant 60% decrease in the content of MDA in the brain with a 2.2-, 2.7-, 3-, and 3.4-fold increase in TAC, SOD, HO-1, and Nrf2, respectively. Co-administration of L. rhamnosus and Thy significantly led to a notable decrease in the content of MDA in the brain (68.6%) and an increase in TAC (3.1-fold), SOD (3.4-fold), HO-1 (2.9-fold), and Nrf2 (3.7-fold) levels compared to those in the PA group.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral levels of oxidative stress biomarkers in PA-induced neurotoxicity. (A) TAC, (B) SOD, (C) HO-1, (D) Nrf2, and (E) MDA. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid. TAC, total antioxidant capacity; SOD, superoxide dismutase; HO-1, heme oxygenase-1; Nrf2, nuclear factor erythroid 2-related factor 2; MDA, malondialdehyde. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs depict the effects of different treatments on five variables: A) TAC, B) SOD, C) HO-1 relative gene expression, D) Nrf2 relative gene expression, and E) MDA. Treatments include Control, PA, PA with Lactobacillus, PA with Thymol, and PA COMB. Statistical significance is indicated with the letters a, b, c, and d.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral levels of apoptotic biomarkers in PA-induced neurotoxicity
Treatment with PA increased the cerebral apoptotic biomarkers AIF, CHI3L, caspase-1, and BAX levels by 9.2, 14.9, 9.7, and 9.5 times, respectively, and decreased anti-apoptotic cerebral Bcl2 levels by 87.6% compared to those in the control group (Figure 6). On the other hand, compared to that in the PA group, treatment with L. rhamnosus resulted in reversed apoptosis by increasing cerebral Bcl2 levels by 3.5 times and decreasing the cerebral levels of AIF, CHI3L, caspase-1, and BAX by 31.2%, 25.8%, 32.6%, and 38.8%, respectively. Additionally, treatment with Thy increased the gene expression levels of Bcl2 by 5.9 times compared to those in the PA group and inhibited the elevated cerebral levels of AIF, CHI3L, caspase-1, and BAX by 49.3%, 51.1%, 57.4%, and 26.2%, respectively, thereby mitigating apoptosis. Additionally, co-administration of L. rhamnosus and Thy led to a significant reduction in the cerebral levels of AIF, CHI3L, caspase-1, and BAX by 73.8%, 51.1%, and 67.7%, respectively, and significantly restored Bcl2 levels by 6.9 times compared to those in the PA group.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral levels of apoptotic biomarkers in PA-induced neurotoxicity. (A) AIF, (B) CHI3L, (C) CASP-1, (D) BAX, and (E) Bcl2. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid. AIF, apoptosis-inducing factor; CHI3L: chitinase-3-like protein 1; BAX: Bcl-2-like protein 4; Bcl2: B-cell lymphoma 2. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Five bar graphs (A-E) show the effects of different treatments (Control, PA, PA + Lactobacillus, PA + Thymol, PA + COMB) on gene expression. Graph A: AIF expression peaks with PA, decreasing with additional treatments. Graph B: CHI3L1 levels are highest with PA alone. Graph C: CASP1 expression follows a similar trend to A. Graph D: BAX expression peaks with PA, then decreases. Graph E: BCL2 expression is lowest with PA, increasing with further treatments. Statistical annotations (a, b, c, d) indicate significant differences between groups.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral <italic>Wnt3/β-catenin/GSK3β</italic> pathways in PA-induced neurotoxicity
Treatment with PA reduced cerebral Wnt3 and β-catenin levels significantly (83.7% and 51.4%, respectively) compared to those in the control group (Figure 7). At the same time, GSK3β gene expression was significantly upregulated by 9.9 times. However, these effects were significantly reversed upon treatment with L. rhamnosus, Thy and their combination compared to those in the PA group. Treatment with L. rhamnosus decreased the cerebral GSK3β gene expression levels by 23.4% and upregulated cerebral Wnt3 and β-catenin levels by 3.4 and 3.1 times, respectively, compared to those in the PA group. Additionally, Thy decreased the expression of GSK3β levels by 45.9% while increasing the levels of Wnt3 and β-catenin by 4.4 and 4.2 times, respectively, compared to that in the PA group. Notably, co-administration of L. rhamnosus and Thy produced the greatest ameliorative effect in restoring the Wnt3/β-catenin/GSK3β pathway compared with the PA group. This was demonstrated by a 5.5-fold increase in the Wnt3 level, a 5.7-fold increase in the β-catenin level, and a 59.1% downregulation of the GSK3β expression levels compared to those in the PA group.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral Wnt3/β-Catenin/GSK3β pathways in PA-induced neurotoxicity. (A) Wnt3, (B) β-catenin, and (C) GSK3β in autistic rats. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid; GSK3β, glycogen synthase kinase-3β. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs labeled A, B, and C display data on Wnt-3a, β-Catenine, and GSK-3β levels, respectively. Each graph shows five groups: Control, PA, PA + Lactobacillus, PA + Thymol, and PA + COMB. Significant differences in data points are noted with letters a, b, c, and d above certain bars. Graph A indicates levels in nanograms per gram of tissue, Graph B in nanograms per liter, and Graph C in nanograms per gram of tissue.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral ER stress and autophagy biomarkers in PA-induced neurotoxicity
As shown in Figure 8, compared to the control group, the PA group exhibited a significant downregulation of cerebral Beclin1 gene expression by 5.3 times and a considerable elevation of cerebral CHOP, PERK, and GRP78 gene expression levels (4.8-, 6.3-, and 7.5-fold, respectively). Conversely, compared to that in the PA group, treatment with L. rhamnosus showed a significant elevation of Beclin1 gene expression by 2.5 times and a significant downregulation of CHOP, PERK, and GRP78 gene expression by 23%, 33.3%, and 29.3%, respectively. In addition, compared to that in the PA group, Thy therapy significantly increased Beclin1 gene expression by 3.5 times while considerably decreasing CHOP, PERK, and GRP78 gene expression levels by 41.7%, 51%, and 36%, respectively. By significantly reducing CHOP, PERK, and GRP78 gene expression by 44%, 66.7%, and 57.3%, respectively, and increasing Beclin1 gene expression by 4 times, the therapy with both L. rhamnosus and Thy in combination significantly had the greatest impact on the elevation of cerebral Beclin1 gene expression and the lowest cerebral levels of CHOP, PERK, and GRP78 gene expression levels compared to that in the PA group.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral ER stress and autophagy biomarkers in PA-induced neurotoxicity. (A)CHOP, (B)PERK, (C)GRP78, and (D) Beclin1. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d): Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid; CHOP, C/EBP homologous protein; PERK, PKR-like ER kinase; GRP78, glucose regulated protein 78. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value <is 0.05.
Bar graphs labeled A to D show relative gene expression under different conditions: Control, PA, PA with Lactobacillus, PA with Thymol, and PA combined (COMB). Each graph presents varying expression levels for CHOP, PERK, GRP78, and Bclin 1. Significant differences are noted with letters a, b, c, and d above certain bars.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral BDNF/<italic>p-TrkB</italic>/CREB pathways in PA-induced neurotoxicity
Compared to that in the control group, PA significantly reduced the cerebral levels of BDNF, p-TrkB, and CREB by 52%, 82%, and 85%, respectively. Conversely, compared to that in the PA group, treatment with L. rhamnosus showed a significant increase in BDNF, p-TrkB, and CREB levels by 1.2-, 2.6-, and 3.2-fold, respectively. In addition, treatment with Thy showed a significant increase in the BDNF, p-TrkB, and CREB levels by 1.3-, 4.8-, and 4.3-fold, respectively. Interestingly, compared to that in the PA group, combined therapy with both L. rhamnosus and Thy significantly boosted BDNF, p-TrkB, and CREB levels by 1.7-, 5.7-, and 5.9-fold, respectively, showing the greatest improvement benefits for each individual therapy (Figure 9).
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral BDNF/p-TrkB/CREB in PA-induced neurotoxicity. (A) BDNF, (B) p-TrkB, and (C) CREB. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid; BDNF, brain-derived neurotrophic factor; p-TrkB, phosphorylated tyrosine protein kinase; CREB, cAMP response element-binding protein. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs titled A, B, and C show data on BDNF levels, p-TRKB, and CREB gene expression, respectively. Each panel compares Control, PA, PA plus Lactobacillus, PA plus Thymol, and PA-COMB groups. Significant differences are marked with letters above bars.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral pI3K/Akt/mTOR pathway in PA-induced neurotoxicity
As shown in Figure 10, compared to the control group, the PA group exhibited a significant elevation of cerebral mTOR gene expression by 5-fold along with significant downregulation of cerebral pI3K and Akt gene expression by 7.6- and 6.7-fold, respectively (Figure 10). Conversely, compared to that in the PA group, administration of L. rhamnosus alone showed a significant downregulation of mTOR gene expression by 1.3 times and a significant elevation of PI3K and Akt gene expression by 3.1 and 2 times, respectively. Similarly, compared to that in the PA group, administration of Thy significantly decreased mTOR gene expression by 1.4 times while significantly increasing PI3K and Akt gene expression by 4.6 and 4 times, respectively.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral pI3K/Akt/mTOR pathway in PA-induced neurotoxicity. (A) pI3K, (B) p-AKT, and (C) mTOR. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid; pI3K, phosphoinositide-3-kinase-Akt-mammalian; AKT, protein kinase B; mTOR, mechanistic target of rapamycin. The mean ± SEM was used to establish the results (n = 6). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar charts labeled A, B, and C show relative gene expression levels. Chart A displays PI3K expression, B shows p-AKT expression, and C depicts m-TOR expression across five treatments: Control, PA, PA + Lactobacillus, PA + Thymol, and PA + COMB. The expressions vary, with statistical annotations a, b, c, d indicating significant differences between groups.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral AMPK and SIRT1 pathways in PA-induced neurotoxicity
As shown in Figure 11, cerebral AMPK and SIRT1 levels were significantly reduced more in the PA group than in the control group by 4.2 and 5.7 times, respectively. However, compared to that in the PA group, these effects were significantly reversed after treatment with L. rhamnosus, Thy and their combination (p < 0.05). Compared that in to the PA group, treatment with L. rhamnosus increased the expression of the SIRT1 and AMPK genes by 2.8 and 2.4 times, respectively. In addition, compared to that in the PA group, Thy elevated cerebral SIRT1 and AMPK gene expression levels by 4.5 and 3.5 times, respectively. Notably, co-administration of both L. rhamnosus and Thy upregulated AMPK and SIRT1 by 4 and 5.2 times, respectively, compared to that in the PA group. Interestingly, the combination of L. rhamnosus and Thy therapy exhibited the greatest ameliorating activity for the restoration of AMPK and SIRT1 compared to the effects of solo therapy.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral AMPK and SIRT1 pathways in PA-induced neurotoxicity. (A) AMPK and (B) SIRT1. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. Significance: p < 0.05. PA, propionic acid; AMPK, AMP-activated protein kinase; SIRT1, sirtuin 1. The mean ± SEM was used to establish the results (n = 6). One way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graphs comparing gene expression levels. Graph A shows AMPK relative gene expression across five groups: Control, PA, PA plus Lactobacillus, PA plus Thymol, and PA plus COMB. Graph B shows SIRT1 relative gene expression for the same groups. Control has the highest expression, while PA has the lowest. The remaining groups show increased expression with annotations indicating statistical significance.Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the cerebral histopathological changes in PA-induced neurotoxicity
Histopathological evaluation of brain tissues was performed in our research; the photomicrographic results are provided in Figure 12.
Therapeutic effects of L. rhamnosus, Thy and their combination on the cerebral histopathological changes in PA-induced neurotoxicity. (Group (A)) Control, (group (B)) PA, (group (C)) PA + L. rhamnosus, (group (D)) PA + Thy, and (group (E)) PA + L. rhamnosus + Thy. Nuclear pyknosis and abnormalities in brain sections are indicated by black arrows (scale bar 25 µm) (n = 4).
Histological images of brain sections from different groups, labeled A to E, displaying the cerebral cortex, striatum, fascia dentata, and subiculum. Each section shows tissue stained in shades of purple and pink, with cellular structures and arrows indicating specific features. Scale bars are present for reference.
In the control group, the photomicrographs showed no marked pathological changes in the cerebral cortex, striatum, fascia dentata, and subiculum (Figures 12A1, 4). However, the PA group showed a high number of necrotic neurons in the cerebral cortex (black arrow) (Figure 12B1), a high number of shrunken and degenerated neurons in the striatum (black arrow) (Figure 12B2), severe nuclear pyknosis in a high number of neurons in the fascia dentate (black arrow) (Figure 12B3), and nuclear pyknosis in a moderate number of neurons in the subiculum (black arrow) (Figure 12B4).
In contrast, upon treatment with L. rhamnosus, we detected a moderate number of shrunken and degenerated neurons (black arrow) in the cerebral cortex and striatum (Figures 12C1, 2), nuclear pyknosis (black arrow) in a moderate number of neurons in the fascia dentata (Figure 12C3), and nuclear pyknosis (black arrow) in a moderate number of neurons in the subiculum (Figure 12C4).
In the same way, the Thy group showed a few degenerated neurons in the cerebral cortex (black arrow; Figure 12D1), a moderate number of shrunken and degenerated neurons in the striatum (black arrow; Figure 12D2), nuclear pyknosis in a moderate number of neurons in the fascia dentata (black arrow; Figure 12D3), and nuclear pyknosis in a few neurons in the subiculum (black arrow; Figure 12D4).
The combined treatment group showed the highest therapeutic effect on brain tissues, where few numbers of degenerated neurons were observed in the cerebral cortex (black arrow; Figure 12E1), few numbers of necrotic neurons were observed in neurons in the striatum (black arrow; Figure 12E2), and no marked pathological changes were observed in the fascia dentata and subiculum (Figures 12E3, 4).
Therapeutic effects of <italic>L. rhamnosus</italic>, Thy and their combination on the immunohistochemical changes in the cerebral cortex in PA-induced neurotoxicity
Immunohistochemical analysis of brain tissues was performed in our research, as illustrated in the photomicrographic results (Figure 13); groups A and E showed negative expression for caspase-1 in neurons of the cerebral cortex (the control group and PA + L. rhamnosus + Thy group). Upon using PA, high positive expression of caspase-1 occurred in the neurons of the cerebral cortex (group B), and moderate positive expression for caspase-1 was observed in the neurons of the cerebral cortex (group C). In group (D), mild positive expression of caspase-1 in the neurons of the cerebral cortex was detected. Statistical analysis in Figure 14 shows the reaction area percent of caspase-1, and the data are represented as the mean ± SD (n = 7); values indicate that these means of the group (PA + L. rhamnosus + Thy) were significantly more variable than that of the other group (p ≤ 0.0001) according to one-way ANOVA and Tukey’s tests.
Effect of L. rhamnosus, Thy and their combination on the brain immunohistochemical changes in PA-induced neurotoxicity. (Group (A)) Control, (group (B)) PA, (group (C)) PA + Lactobacillus, (group (D)) PA + Thy, and (group (E)) PA + COMB. Abnormalities in the brain are indicated by black arrows (n = 4).
Microscopic images labeled A to E show tissue samples with varying cell densities and staining patterns. Image A displays a sparse distribution of cells. Images B, C, and D highlight specific areas with arrows, indicating areas of interest amidst stained structures. Image E shows a more uniform distribution. Each image includes a scale bar representing 25 micrometers.
Quantitative analysis of the therapeutic effects of Lactobacillus rhamnosus (L. rhamnosus) and/or thymol (Thy) on the immunohistochemical changes in caspase-1 in the cerebral cortex in PA-induced neurotoxicity. (Group A) Control, (group B) PA, (group C) PA + L. rhamnosus, (group D) PA + Thy, and (group E) PA + L. rhamnosus + Thy. Abnormalities in the brain are indicated by black arrows. (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus. (d) Significance relative to the PA + Thy group. PA, propionic acid. The mean ± SEM was used to establish the results (n = 4). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graph titled "Caspase 1" shows mean area percentages on the y-axis and various treatments on the x-axis: Control, PA, PA + Lactobacillus, PA + Thymol, and PA + COMB. PA has the highest mean at around 27%, followed by PA + Lactobacillus at about 17%, PA + Thymol at roughly 10%, and PA + COMB near 3%. Statistical significance is indicated by letters above each bar.Therapeutic effects of <italic>Lactobacillus rhamnosus</italic>, Thy and their combination on the immunohistochemical changes in the cerebral striatum in PA-induced neurotoxicity
The effect of treatment with L. rhamnosus, Thy and their combination on caspase-1 in the neurons of the striatum was studied in our research (Figure 15). Group (A) showed negative expression for caspase-1 in the neurons of the striatum in the normal control group. In group (B), a high positive expression for caspase-1 was detected in the neurons of the striatum in the control positive group. Regarding groups C and D, moderate positive expression for caspase-1 was found in the neurons of the striatum. In group (E), we detected mild positive expression for caspase-1 in the neurons of the striatum. Figure 16 showed the quantitatively estimated reaction area percentage of caspase-1, and data are represented as the mean ± SD (n = 7). Values indicate that the mean of group E was significantly more variable than that of other groups (p ≤ 0.0001) according to one-way ANOVA and Tukey’s tests.
Therapeutic effects of Lactobacillus rhamnosus (L. rhamnosus) and/or thymol (Thy) on the immunohistochemical changes in the cerebral striatum in PA-induced neurotoxicity. (Group (A)) Control, (group (B)) PA, (group (C)) PA + Lactobacillus, (group (D)) PA + Thy, and (group (E)) PA + COMB. Abnormalities in the brain are indicated by black arrows (n = 4).
Five microscopic images labeled A to E displaying brain tissue sections. Each panel shows a different staining pattern highlighting cellular structures with varying densities and colors. Scale bars indicate 25 micrometers.
Quantitative analysis of the therapeutic effects of Lactobacillus rhamnosus (L. rhamnosus) and/or thymol (Thy) on the immunohistochemical changes of caspase-1 in the cerebral striatum in PA-induced neurotoxicity. (Group A) Control, (group B) PA, (group C) PA + L. rhamnosus, (group D) PA + Thy, and (group E) PA + L. rhamnosus + Thy. Abnormalities in the brain are indicated by black arrows. Data are presented as the means ± SE (n = 7). (a) Significance relative to the control group. (b) Significance relative to the PA group. (c) Significance relative to the PA + Lactobacillus rhamnosus group. (d) Significance relative to the PA + Thy group. PA, propionic acid. The mean ± SEM was used to establish the results (n = 4). A one-way ANOVA test was used, followed by Tukey’s post hoc test, and the represented p-value is <0.05.
Bar graph comparing mean area percentages of Caspase 1 expression. The bars represent Control, PA, PA + Lactobacillus, PA + Thymol, and PA + COMB. PA shows the highest mean area, while Control shows the lowest. Letters above bars indicate statistical significance differences.Discussion
Our study investigated the neuro-therapeutic effects of L. rhamnosus, Thy and their combination on the histological features, behavioral outcomes, neurotransmitters, oxidative stress, ER stress, autophagy, inflammation, apoptosis, and neuronal integrity in a PA-induced ASD rat model (graphical abstract).
According to our findings, L. rhamnosus, Thy and their combination greatly improved social and cognitive behaviors, decreased oxidative damage, decreased inflammation, maintained neuronal integrity, and restored normal pathways (Xiong et al., 2023). To the best of our knowledge, this is the first research that studies how L. rhamnosus, Thy and their combination can be used to treat rats with PA-induced autism.
The Y-maze, CAR, and OFT tests are frequently used to analyze learning, memory, and exploratory anxious cognitive and deficit behavior (Salehi et al., 2018). Motor development was measured by evaluating the swimming performance. Swimming activity was lower in the PA group (Capibaribe et al., 2019). According to our findings, PA greatly reduced SAP, significantly prolonged latency, and significantly decreased rearing and the frequency of ambulation. PA increased the immobility score while drastically decreasing the swimming score. On the first and second days, the PA group showed an increased number of avoidance responses to the electric shock. Therefore, in line with earlier research, our findings demonstrated that higher PA exposure causes autism-like behavior in rats (Sunand et al., 2020; Bagcioglu et al., 2023). Similarly, several studies reported that PA causes repetitive motions, aberrant motor behavior, and social behavior impairment (Choi et al., 2018; Thomas et al., 2012).
Confirming our findings, we also noted that several behavior tests were conducted over the past 15 years to assess the characteristics of the PA model. Social impairment in the tested rats, both with strangers and with each other, was the most unexpected observation (Kılıç et al., 2025; Mirza and Sharma, 2018; Shams et al., 2019; MacFabe et al., 2007). Movement disorders were characterized by repeated, stereotyped behavior that lacks a suggested pattern. PA demonstrated impaired cognition (Ma et al., 2011; Shams et al., 2019; Ali et al., 2020), location avoidance (Eissa et al., 2020; Ossenkopp et al., 2012), repetitive behavior (Kamen et al., 2019; Shultz et al., 2009), rearing (Ali et al., 2020; Shultz et al., 2009), and hyposensitivity and reduced exploration (Kamen et al., 2019). It is well-known that PA, a metabolite typically produced by the overgrowth of bacteria such as clostridia and others, can effectively cause rodents to exhibit chronic autistic symptoms (Bin-Khattaf et al., 2022).
Our results showed that L. rhamnosus, Thy and their combination had therapeutic benefits on behavioral outcomes, with both medications significantly improving the results of the employed behavioral tests when taken either alone or in combination. In addition to showing a significant improvement in open-field test results, the therapeutic effect of L. rhamnosus, Thy and their combination may increase SAP%, with significant improvement in swimming scores and decreased immobility scores, associated with a significant reduction in the number of electric shock avoidance response trials, all of which suggested behavioral change. Thy was able to return the observed behavioral parameter to its typical values after co-treatment with both L. rhamnosus and Thy.
In accordance with our findings, tests on Lact1 showed that the treatment with L. rhamnosus strains improved the autistic-like behaviors. Additionally, lactobacilli were able to maintain motor performance (Capibaribe et al., 2019; Al-Salem et al., 2016) and the swimming rate. In addition, L. rhamnosus therapy restored spontaneous alteration and cognitive capacity in the maze test. Improved memory and navigation abilities are two ways in which L. rhamnosus therapy affects the gut–brain connection (Capibaribe et al., 2019). Likewise, it was discovered that L. rhamnosus treatment significantly enhanced autistic-like behaviors in mice and that after 3 weeks of treatment, social behavior impairments were reversed in this model. Therefore, L. rhamnosus treatment successfully reduced core ASD-like symptoms, indicating that it may be used therapeutically to improve core ASD symptoms over a longer treatment period (Rosenfeld, 2015).
Accordingly, earlier research showed that probiotic administration can considerably reduce ASD symptoms in both humans and animals (Park et al., 2025; Hsiao et al., 2013; West et al., 2013). Male mice were more inclined to interact with stranger mice after receiving L. rhamnosus treatment for 2 weeks in the model of ASD, indicating an improvement in sociability. Meanwhile, L. rhamnosus reduced freezing and self-grooming behaviors in female mice (Kałużna-Czaplińska et al., 2012).
Therefore, L. rhamnosus treatment successfully reduced core ASD-like symptoms, indicating that it may be used therapeutically to improve core ASD symptoms over a longer treatment period.
Regarding Thy, in accordance with our results, Thy’s antidepressant-like effects were favorably demonstrated by a decrease in immobility time in the forced swimming test. These tests are based on the premise that stressful events elicit fight-or-flight responses (Guo et al., 2022; Vasconcelos et al., 2015). Additionally, Cavalcanti et al. concluded that immobility is strongly linked to hopelessness and depressive-like behavior and that Thy was successful in reversing these characteristics (Salehi et al., 2018). In addition, Xiong et al. (2023) stated that in ASD rats, Thy therapy alleviates repetitive stereotyped behaviors, motor activity, and social impairments. Thy was administered to rats for a brief period of time to improve their social deficiencies (Xiong et al., 2023).
In vitro and in vivo studies have demonstrated that Thy can enhance gut microbiota (Steru et al., 1985). By producing neuroactive metabolites, the gut microbiota was shown to control rat behavior in an in vivo model (Liu et al., 2022). Thus, through the gut microbiome, Thy may influence ASD. Through proven behavioral models (hole-board and light/dark tests), several studies established Thy’s anxiolytic character, suggesting that its effects on OFT and FST may be obscured by decreased anxiety. The concurrent repair of biochemical and structural abnormalities in our investigation demonstrates that the advantages reflect a meaningful neurotherapeutic effect beyond simple sedation, even though this pharmacological action contributes to the observed behavioral improvement (Capibaribe et al., 2019). However, the simultaneous restoration of several biochemical pathways and neural integrity indicates that the advantages go beyond simple sedation.
Therefore, behavioral studies, biochemical indicators, and literature data demonstrated that the medication dose employed in our investigation was both safe and effective in improving PA-induced neurobehavioral deficits. This creates several opportunities for Thy’s clinical use. It is important to note that the behavioral tests used in this work (Y-maze, CAR, OFT, and FST) primarily evaluate depressive-like behavior, anxiety, and cognitive flexibility, which are common comorbidities in ASD. To directly evaluate fundamental social deficiencies, future research should include social interaction tests (such as the three-chamber exam).
In the pathophysiology of ASD, alterations of the monoaminergic neurotransmitter have been found in numerous brain areas and in the peripheral system (Sharon et al., 2019).
Our results showed that PA-induced autistic rats showed diminished levels of brain neurotransmitters DA, NE, 5-HT, and GABA. Our findings are consistent with those of other studies that showed that the decrease in brain monoamines may be the cause of the observed deterioration in the behavioral outcomes in the PA group (Kuo and Liu, 2022; Rahi et al., 2021). Moreover, according to earlier research, dopaminergic dysfunction, particularly DA imbalance in a particular brain region, may be the etiology of ASD (Tiwari et al., 2021). Neurodevelopmental disorders such as ASD are associated with changes in the distribution of serotonin and NE (Marotta et al., 2020; Kubota et al., 2020). Numerous studies have demonstrated that autism, particularly in the early stages of brain development, exhibits an imbalance in serotonin levels (Tiwari et al., 2021; Hwang et al., 2017), where lower 5-HT availability was observed in the brain stem and the total gray matter (Muller et al., 2016). Accordingly, glutamate and GABA were altered in the PA model, which was in contrast to the control (Andersson et al., 2021; MacFabe, 2013).
According to the majority of these studies, autism is associated with lower GABA levels (El-Ansary et al., 2011; Puts et al., 2017; Rojas et al., 2014). Other research, however, has shown that individuals with ASD have higher GABA levels. While Cid-Jofré et al. (2022) showed that the GABA level increased in their experimental autism study, Maier et al. (2022) and El-Ansary and Al-Ayadhi (2014) revealed that the GABA level was higher in individuals with autism.
Additionally, some research has clarified how GABA affects neuroinflammation (Crowley et al., 2016). GABA balance can be impacted by several processes, and neuroinflammation can significantly exacerbate an imbalance. More research is required to ascertain whether GABA neurotransmission is compromised in autistic cases and elucidate how modafinil affects GABA (Sunand et al., 2020).
Our findings demonstrated the anti-autistic effects of L. rhamnosus, Thy and their combination, as demonstrated by a significant increase in DA, NE, 5-HT, and GABA.
In accordance with our results, Wei et al. (2019) recorded that L. rhamnosus was also able to reverse the reduction in the serotonin and dopamine levels in mice. Similarly, Desbonnet et al. (2008) reported enhancement of the neurotransmitters NE, dopamine, and serotonin in probiotic-autistic rats.
Accordingly, it was recorded that probiotics can promote the availability of additional monoamine precursors, function as a digestive aid to improve nutritional contents, replace pathogenic microorganisms, and ultimately increase serotonin, dopamine, and NE levels. Additionally, probiotics increased the expression of synaptophysin mRNA and dopamine receptor subtypes D1 and D2, along with the cellular response and monoamine release (Rehman et al., 2022).
Furthermore, investigations provide compelling proof that L. rhamnosus has beneficial effects on dopamine function and metabolism (Hamamah et al., 2022). In addition, two crucial enzymes in dopamine metabolism, tyrosine hydroxylase and dopamine β-hydroxylase, along with plasma cortisol, were decreased by Lactobacillus plantarum DR7 (Liu et al., 2020).
Additionally, studies revealed that as GABA-producing organisms, L. rhamnosus may be strong candidates for altering the glutamate/GABA ratio, making them potentially effective treatments for social behavioral symptoms associated with ASD (Yunes et al., 2020; Mintál et al., 2022; El-Ans and ary, 2024). In line with earlier research, Thy increased DA and NE levels in the brain (Mirza and Sharma, 2018; Javed et al., 2019; Kassab and El-Hennamy, 2017; Kuzay et al., 2022; Ogaly et al., 2022; Abu-Elfotuh et al., 2022b; Esnafoglu et al., 2017; Khayyat et al., 2025; El-Ansary, 2016). Thy-pretreatment showed significant increases in catecholamine for DA, NE, and 5HT (Abu-Elfotuh et al., 2022b).
Neurological problems are directly linked to oxidative stress; it was found that administration of PA treatment affects oxidative stress markers (Shultz et al., 2009; Rahi et al., 2021). In light of this result, we concluded that the development of autism is significantly influenced by oxidative stress. Our results showed that in contrast to the control group, PA-treated rats in our study exhibited a substantial increase in the oxidative stress marker MDA and a decrease in the levels of the antioxidants TAC, SOD, HO-1, and Nrf2. In rats administered PA, the therapeutic effect of L. rhamnosus, Thy and their combination markedly increased the antioxidant levels and decreased oxidative stress indicators.
Overproduction of reactive oxygen species is linked to oxidative stress in macrophages and microglia, which starts a destructive cycle of neuroinflammation and cellular damage. The pathophysiology of autism spectrum diseases, which includes behavioral abnormalities, cell death, and neuronal malfunction, is significantly influenced by these processes (Kılıç et al., 2025).
These findings are in line with earlier research by Esnafoglu et al. (2017), Tiwari et al. (2021), and Khayyat et al. (2025), who found that oxidative stress is a major mechanism of PA toxicity. Our findings were also consistent with several earlier studies that showed changes in several biomarkers linked to glutamate excitotoxicity and oxidative stress in a rat model of autism produced by PA (Bin-Khattaf et al., 2022; El-Ansary, 2016; El-Ansary et al., 2012; Aldbass et al., 2013).
Similarly, other research showed elevated oxidative stress markers in ASD (Alfawaz et al., 2022; Erbas et al., 2018; Kamalmaz et al., 2023; MacFabe et al., 2008); the elevated MDA levels in the PPAS group validated the role of oxidative stress in the PA-induced autism model (Sunand et al., 2020). In accordance with our results, Hussein et al. (2023) investigated gated Thy’s ability to prevent SOD activity, and the measurement of MDA and GSH levels was used to assess the antioxidant activity. Moreover, Gago et al. (2025) claimed that Thy prevents oxidative stress.
In our work, PA modulated the TLR4, TNF-α, IL-1β, NF-κβ, and NLRP3 inflammasome pathways, indicating an inflammatory response. However, treating PA-induced autistic rats with L. rhamnosus, Thy and their combination dramatically lessened the negative effects of PA on these markers, suggesting that these medications have anti-inflammatory properties. Remarkably, the group treated with the combination of both agents showed superior outcomes compared with the MSG-treated group and the groups receiving either treatment alone.
Numerous investigations in agreement with our results have demonstrated a strong correlation between ASD and inflammatory cytokines (Xie et al., 2017). Abu-Elfotuh et al. (2022b)Kılıç et al. (2025) assessed the effects of PA administration on key indicators of inflammation, including TLR4, TNF-α, IL-1β, NF-κβ, and the NLRP3 inflammasome. Increased astrocyte or microglia activity has been shown to produce aberrant immunological profiles, which are implicated in the pathophysiology of ASD (Petrelli et al., 2016).
In addition, numerous studies have demonstrated that TLR4 activates the NF-κB pathway, which, in turn, causes the production of inflammatory mediators (Kumar, 2019; Sharif et al., 2007). The NF-κB pathway plays a role in the development and onset of inflammatory disorders by regulating the inflammatory subcellular events (Guo et al., 2022). Furthermore, the generation of IL-1β is triggered by the activation of the NLRP3 inflammasome on astrocytes, which binds to its receptors on glial cells and intensifies the inflammatory response.
In accordance with our results, research reported that L. rhamnosus showed anti-inflammatory properties (Rosenfeld, 2015; Guo et al., 2015; Martinon and Tschopp, 2007; Song et al., 2017). This could occur through interactions with the altered microbiota, leading to modulation of the serotonergic system by reducing gut permeability and modifying inflammatory processes (Corridoni et al., 2012; Leber et al., 2012; Lyte et al., 2020; O’Mahony et al., 2015; Ruiz et al., 2017).
Many studies agreed with our results and showed that Thy appears to be safe in terms of side effects and has been demonstrated to reduce inflammation by reducing the initiation and advancement of the inflammatory processes in many animal models of human diseases (Meeran et al., 2016; Meeran et al., 2015; Riella et al., 2012). Moreover, Javed et al. (2019) found that Thy administration dramatically decreased pro-inflammatory cytokine release and activation, as demonstrated by the decreased levels in the rats’ brain tissues.
Accordingly, it has been shown that Thy reduced inflammation via controlling the NF-κB pathways mediated by TLR4 (Wu et al., 2017). Additionally, Thy may exert its previously reported antidepressant effect by inhibiting the activation of the NLRP3 inflammasome, which, in turn, may reduce the production of caspase-1 (Zhang et al., 2021). Accordingly, in Zhao et al., Thy therapy significantly decreased the production of these pro-inflammatory factors. Inflammatory receptors such as TLR can be stimulated to activate NF-κB, which is well-known for controlling inflammation and immunity (Nennig and Schank, 2017).
According to these experimental results, Thy inhibited the phosphorylation of IκB, which, in turn, decreased NF-κB’s translocation to the nucleus and the subsequent release of inflammatory mediators triggered by NF-κB (Zhao et al., 2024). It has been discovered that neuronal apoptosis is linked to autistic behavior. A previous study established this association by demonstrating increased BAX expression and decreased BCL2 expression in the hippocampus tissues of a mouse model of autism (Ming et al., 2022). While extra Bax speeds up apoptotic cell death and AIF translocation causes apoptosis in a caspase-independent manner, BCL2 preserves the integrity of the mitochondrial membrane, favoring cell survival (Mathew and Keerikkattil, 2021).
Similarly, our results showed that reduced anti-apoptotic BCL2 and increased pro-apoptotic apoptotic factors, including AIF, CHI3L, CASP1, and BAX, indicated enhanced apoptosis in the PA group. On the other hand, treatment with L. rhamnosus, Thy and their combination reversed apoptosis by lowering the apoptotic factors and increasing the anti-apoptotic BCL2.
Our findings were consistent with a prior study that found that Thy treatment had anti-apoptotic effects, as evidenced by a significant increase in Bcl-2 mRNA expression by 8.2- and 9-fold, respectively, and a significant decrease in Bax and AIF mRNA expression by a similar amount compared to that in the PA group (Xiong et al., 2023). In addition, according to Amin et al. (2023), L. rhamnosus can interact with proteins that control the inherent resistance to apoptosis. By activating pro-caspases, downregulating anti-apoptotic Bcl-2, and upregulating pro-apoptotic Bax proteins, lactobacilli can overcome this resistance (Amin et al., 2023; Wang et al., 2025).
Many studies agreed with our results regarding Thy as an apoptotic factor; by interfering with mitochondrial membrane potential and ROS production, Thy treatment shows a decrease in cell number and cell apoptosis (Thapa et al., 2019; Chauhan et al., 2017). De La Chapa et al. (2018) also observed that Thy reduced HeLa cell viability and PARP cleavage-induced death, indicating that mitochondrial malfunction and subsequent apoptosis are the cause of Thy’s action.
It is evident that long-term ER stress may play a role in the buildup of misfolded proteins, which leads to neuronal death and subsequent neurodegeneration (Mou et al., 2020). GRP78 activates PERK in ER stress, which activates CHOP, a pro-apoptotic factor. CHOP can cause a series of detrimental effects on neurons, including the production of ROS, inflammation, and apoptotic cascades, by decreasing the anti-apoptotic protein BCL-2 and increasing the pro-apoptotic proteins BAX, AIF, and CASP1 (Saha et al., 2021).
Our findings demonstrated that PA-induced autistic rats exhibited elevation of CHOP, PERK, and GRP78 gene expression, which are indicators of prolonged ER stress, in accordance with the aforementioned cascade. Surprisingly, when administering L. rhamnosus, Thy and their combination, these negative effects are reversed (Bouhtit et al., 2021). Our results were consistent with other research that demonstrated that Thy may have an effect by causing the expression of procaspase-3 and procaspase-9 to decrease while CHOP expression increases. In vivo and in vitro, ROS can cause ER stress or vice versa, and CHOP is implicated in reticular stress (Han et al., 2018).
Our results showed that compared to those in the control group, the PA group’s levels of BDNF, p-TrkB, CREB, AMPK, and SIRT1 were highly reduced. This was accompanied by a significant decrease in Wnt3 and β-catenin levels and a concurrent increase in GSK3β gene expression. In contrast to those in the PA group, these alterations were significantly reversed by treatment with L. rhamnosus and Thy. The observed modulation of a neurotrophic signaling cascade, which may be the cause of the enhanced cognitive function, is consistent with the reported increase in BDNF and CREB after L. rhamnosus, Thy and their combination therapy.
According to Abu-Elfotuh et al., Thy dramatically increased the content of BDNF in the brain, Wnt3a, and β-catenin mRNA expression, which is consistent with our findings (Xiong et al., 2023). In addition to activating the BDNF pathway, Thy was discovered to have anti-oxidative and anti-inflammatory properties that contribute to its neuro-therapeutic benefits (Yang et al., 2015). Similarly, GSK-3β activity is reduced by BDNF overexpression, but the major Wnt signaling molecules and their downstream target β-catenin are upregulated (Yang et al., 2015). Accordingly, β-catenin’s nuclear translocation and the transcription of its target genes, including BDNF, are caused by the stimulation of the Wnt/β-catenin pathway (Zhang et al., 2018; Yi et al., 2012). On the other hand, the observed neuro-therapeutic effects in midbrain dopaminergic neurons are caused by the inhibition of inflammation through the activation of the Wnt pathway (L’episcopo et al., 2011).
Interestingly, studies showed that Thy counteracted the downregulation of β-catenin and Wnt3a (Ojetunde, 2024). Thus, Wnt3/β-catenin activation upregulates BDNF, which is essential for synaptic plasticity and reversing learning and memory deficits (Mohamed et al., 2021; Abu-Elfotuh et al., 2022c).
Compared to the control group, our results demonstrated that PA-induced autistic rats showed a significant elevation of mTOR gene expression and a significant downregulation of pI3K and Akt gene expression. Conversely, pI3K and Akt gene expression were significantly upregulated following L. rhamnosus, Thy and their combination treatment.
Our results were consistent with prior research showing that mTOR inhibition can enhance social interaction and PI3K/AKT/mTOR-mediated autophagic activity in ASD, offering a new target and avenue for ASD treatment. According to Poultney et al. (2013), autophagy-related genes have exonic copy number variation mutations linked to ASD. This suggests that autophagy failure is a contributing factor to ASD. Through the IGF-1/PI3K/AKT/mTOR pathway, the mammalian target of rapamycin (mTOR), a master regulator of cell proliferation, cellular metabolism, and autophagy, has been implicated in the development of ASD (Bozdagi et al., 2013). In this context, we believe that autophagy may be promoted or suppressed through the PI3K/AKT/mTOR pathway, thereby influencing the development of ASD (Yang et al., 2015).
Regarding the impact of Thy on autophagy, Dou et al. (2022) found that Thy significantly restored autophagy by measuring the levels of genes and proteins associated with autophagy. This suggests that Thy suppresses the inflammasome by inducing autophagy. Furthermore, the mechanism by which Thy regulates autophagy via the AMPK/mTOR axis is a well-known and traditional route among the many routes that control autophagy (Li et al., 2022). Autophagy is triggered when AMPK is activated as p-AMPK as it inhibits the conversion of mTOR to p-mTOR (Yang et al., 2019). Our findings were consistent with these results.
Furthermore, according to studies, Thy administration significantly decreased the phosphorylation of PI3K, Akt, and mTOR. PI3K’s main downstream target is Akt, which is also referred to as protein kinase B (PKB) (Liu et al., 2020; Herrera-Bravo et al., 2024), and one of Akt’s downstream effectors is mTOR. A key regulator linked to cellular autophagy is the PI3K/Akt/mTOR pathway (Wang et al., 2020; Ye et al., 2020). It is worth mentioning that inflammation can be decreased by promoting microglial autophagy (Chen et al., 2024; Hegdekar et al., 2023).
It has previously been demonstrated that administering L. rhamnosus to elderly rats can improve memory and decrease mTOR activation in the hippocampus, suggesting that it is effective in reducing age-related degenerative dementia (Kumar et al., 2020; Jeong et al., 2015). According to another investigation, the mTOR and Wnt/β-catenin pathways can be differently modulated by the culture of L. rhamnosus (Taherian-Esfahani et al., 2016). Another study reported similar results in a mouse model (Fu et al., 2017). Furthermore, it has been demonstrated that L. rhamnosus activates apoptosis by suppressing the expression of NF-κB and lowering the phosphorylation of mTOR elements such as Akt, PI3K, and p70S6 kinase (Hwang et al., 2013).
Recently, Wang et al. (2025) confirmed that L. rhamnosus exopolysaccharides induce autophagy and apoptosis and reduced the expression of phosphorylation levels of PI3K, AKT, and mTOR.
Our results demonstrate that exopolysaccharides from Lactobacillus plantarum reduce the expression of the phosphorylation levels of PI3K, AKT, and mTOR and cause autophagy and apoptosis.
One of the suggested mechanisms for L. rhamnosus is via neuroactive metabolite synthesis, such as SCFAs like butyrate, although this effect was not particularly assessed in this study.
SCFAs promote the secretion of gastrointestinal peptides and glucagon-like peptide 1 from the intestinal L-cell, which directly or indirectly inhibit NLRP3 inflammasome activation and ROS (Jackson et al., 2019; Scuto et al., 2024).
SCFA supplementation effectively reversed neuropathological aspects such as apoptosis activation, neuroinflammation amplification, and synaptic density loss. Possible therapeutic approaches include microbiota-derived SCFAs that may exert neuroprotection through BDNF-dependent PI3K/Akt signaling (Liu et al., 2025). Moreover, SCFAs’ bioactive polyphenol metabolites have the ability to influence particular pathways that determine the modulation of particular target genes; specifically, the Nrf2 pathway is activated to produce its antioxidant action (Zhou et al., 2019; Cuciniello et al., 2023).
Limitations
It is worth mentioning that the acute nature of the PA model represents a limitation in our study. Therefore, future studies should investigate the effects of a chronic PA-induced autism model and compare outcomes between the acute and the chronic models.
It is crucial to remember that the PA model causes significant, pervasive neurochemical alterations that might indicate an acute neurotoxic condition. The results should be evaluated with the knowledge that this model may not accurately capture the more nuanced and developmental pathophysiology of human ASD, even though it helps screen therapeutic drugs.
It is important to clarify that the role of microbiota modulation as a suggested mechanism underlying the observed effects was hypothesized based on existing literature rather than being directly tested in this study.
The use of whole-brain homogenates for biochemical and molecular analyses represents a major limitation of the study. This method may obscure region-specific changes in nuclear circuits, including the prefrontal cortex, hippocampus, and cerebellum, which are crucially involved in ASD. Future research should concentrate on analyzing these particular brain areas.
While one-way ANOVA with Tukey’s test was used for all comparisons, the problem of multiple comparisons should be taken into account when interpreting the many important findings from the exploratory analyses.
Conclusion
The exposure to PA may lead to autistic behavior presented by abnormalities in neurotransmitter levels, oxidative stress, pro-inflammatory factor release, autophagy, ER stress, and apoptosis. PA-induced neurotoxicity and behavioral deficits were reduced by L. rhamnosus and Thy, with their combined therapy demonstrating stronger effects. The normalization of oxidative stress, inflammatory, apoptotic, and neurotrophic indicators was linked to these improvements. The results are still preliminary and model-specific, but they are encouraging. Microbiome analysis, region-specific molecular assays, route validation studies, and behavioral testing tailored to ASD should all be part of future research.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.
Ethics statement
The animal study was approved by the NIH Guideline for the Care and Use of Laboratory Animals (NIH Publications No. 85–23, updated 2011). Moreover, the Animal Ethics Committee of the Faculty of Pharmacy (Girls), Al-Azhar University, Egypt (No.384/2023), oversaw all animal-handling operations. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
HS: Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Supervision, Writing – review and editing. NR: Conceptualization, Project administration, Supervision, Writing – review and editing. MuA: Data curation, Formal analysis, Software, Visualization, Writing – original draft. RhA: Data curation, Software, Validation, Visualization, Writing – original draft. HeA: Data curation, Software, Validation, Visualization, Writing – original draft. AH: Data curation, Formal analysis, Investigation, Writing – original draft. AA: Resources, Validation, Writing – original draft. MnA: Resources, Validation, Writing – original draft. RnA: Formal analysis, Resources, Writing – original draft. RwA: Formal analysis, Resources, Writing – original draft. MrA: Formal analysis, Resources, Writing – original draft. HaA: Resources, Validation, Writing – original draft. KA-E: Conceptualization, Formal analysis, Methodology, Supervision, Writing – review and editing.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2025.1728908/full#supplementary-material
Edited by:Marta Llansola, Principe Felipe Research Center (CIPF), Spain
Reviewed by:Muhammad Ikram, The University of Texas Health Science Center at San Antonio, United States
Kubilay Doğan Kiliç, Ege University, Türkiye
ReferencesAbdelliL. S.SamsamA.NaserS. A. (2019). Propionic acid induces gliosis and neuro-inflammation through modulation of PTEN/AKT pathway in autism spectrum disorder. Sci. Reports9 (1), 8824. 10.1038/s41598-019-45348-z31217543Abu-ElfotuhK.Abdel-SattarS. A.AbbasA. N.MahranY. F.AlshanwaniA. R.HamdanA. M. E. (2022a). The protective effect of thymoquinone or/and thymol against monosodium glutamate-induced attention-deficit/hyperactivity disorder (ADHD)-like behavior in rats: modulation of Nrf2/HO-1, TLR4/NF-κB/NLRP3/caspase-1 and Wnt/β-Catenin signaling pathways in rat model. Biomed. and Pharmacother.155, 113799. 10.1016/j.biopha.2022.11379936271575Abu-ElfotuhK.HamdanA. M. E.MohammedA. A.AtwaA. M.KozmanM. R.IbrahimA. M. (2022b). Neuroprotective effects of some nutraceuticals against manganese-induced Parkinson’s disease in rats: possible modulatory effects on TLR4/NLRP3/NF-κB, GSK-3β, Nrf2/HO-1, and apoptotic pathways. Pharmaceuticals15 (12), 1554. 10.3390/ph1512155436559006Abu-ElfotuhK.HusseinF. H.AbbasA. N.Al-RekabiM. D.BarghashS. S.ZaghloolS. S. (2022c). Melatonin and zinc supplements with physical and mental activities subside neurodegeneration and hepatorenal injury induced by aluminum chloride in rats: inclusion of GSK-3β-Wnt/β-catenin signaling pathway. Neurotoxicology91, 69–83. 10.1016/j.neuro.2022.05.00235526705Abu-ElfotuhK.SelimH. M. R. M.RiadO. K. M.HamdanA. M.HassaninS. O.SharifA. F. (2023). The protective effects of sesamol and/or the probiotic, Lactobacillus rhamnosus, against aluminum chloride-induced neurotoxicity and hepatotoxicity in rats: modulation of Wnt/β-catenin/GSK-3β, JAK-2/STAT-3, PPAR-γ, inflammatory, and apoptotic pathways. Front. Pharmacol.14, 1208252. 10.3389/fphar.2023.120825237601053Al-SalemH. S.BhatR. S.Al-AyadhiL.El-AnsaryA. (2016). Therapeutic potency of bee pollen against biochemical autistic features induced through acute and sub-acute neurotoxicity of orally administered propionic acid. BMC Complementary Altern. Med.16 (1), 120. 10.1186/s12906-016-1099-827107819AlbrakatiA.AlsharifK. F.Al OmairiN. E.AlsanieW. F.AlmalkiA. S.Abd ElmageedZ. Y. (2021). Neuroprotective efficiency of prodigiosins conjugated with selenium nanoparticles in rats exposed to chronic unpredictable mild stress is mediated through antioxidative, anti-inflammatory, anti-apoptotic, and neuromodulatory activities. Int. J. Nanomedicine16, 8447–8464. 10.2147/IJN.S32343635002238AldbassA. M.BhatR. S.El-AnsaryA. (2013). Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats. J. Neuroinflammation10 (1), 837. 10.1186/1742-2094-10-4223537042AlfawazH. A.El-AnsaryA.Al-AyadhiL.BhatR. S.HassanW. M. (2022). Protective effects of bee pollen on multiple propionic acid-induced biochemical autistic features in a rat model. Metabolites12 (7), 571. 10.3390/metabo1207057135888695AliA.KhalilM.ElarinyH.Abu-ElfotuhK. (2017). The role of mental and physical activities against development of Alzheimer’s disease in socialized and isolated rats (TDR). Brain Disord. Ther.6 (240), 2.AliE. H.HassanM. K.AbbasO. A.E ElmalahyH.Abu AlmaatyA. H. (2020). Uritica dioica improves brain dysfunctions in propionic acid autistic like rat model through brain monoamines and mitochondrial energy. Afr. J. Biol. Sci.16 (1), 207–231. 10.21608/ajbs.2020.133010AliE. H.ElmalahyH. A. E.AbbasO. A.Abu AlmaatyA. H. (2022). Is propionic acid a suitable model for autism?Alfarama J. Basic and Appl. Sci.3 (1), 45–63. 10.21608/ajbas.2021.82905.1058AlsubaieiS. R. M.AlfawazH. A.AlmubarakA. Y.AlabdaliN. A.Ben BachaA.El-AnsaryA. (2022). Independent and combined effects of probiotics and prebiotics as supplements or food-rich diets on a propionic-acid-induced rodent model of autism spectrum disorder. Metabolites13 (1), 50. 10.3390/metabo1301005036676975AltomiZ. A.AlsakarY. M.El-GayarM. M.ElmogyM.FoudaY. M. (2025). Autism spectrum disorder diagnosis based on attentional feature fusion using NasNetMobile and DeiT networks. Electronics14 (9), 1822. 10.3390/electronics14091822AminM.NavidifarT.SaebS.BarzegariE.JamalanM. (2023). Tumor-targeted induction of intrinsic apoptosis in colon cancer cells by Lactobacillus plantarum and Lactobacillus rhamnosus strains. Mol. Biol. Rep.50 (6), 5345–5354. 10.1007/s11033-023-08445-x37155013AnderssonM.TangenÄ.FardeL.BölteS.HalldinC.BorgJ. (2021). Serotonin transporter availability in adults with autism—a positron emission tomography study. Mol. Psychiatry26 (5), 1647–1658. 10.1038/s41380-020-00868-332848204AspideR.CarnevaleU. A. G.SergeantJ. A.SadileA. G. (1998). Non-selective attention and nitric oxide in putative animal models of Attention-Deficit Hyperactivity Disorder. Behav. Brain Research95 (1), 123–133. 10.1016/s0166-4328(97)00217-9BagciogluE.SolmazV.ErbasO.ÖzkulB.ÇakarB.UyanikgilY. (2023). Modafinil improves autism-like behavior in rats by reducing neuroinflammation. J. Neuroimmune Pharmacol.18 (1), 9–23. 10.1007/s11481-023-10061-237043086Bin-KhattafR. M.AlonaziM. A.Al-DbassA. M.AlmnaizelA. T.AloudahH. S.SolimanD. A. (2022). Probiotic ameliorating effects of altered GABA/glutamate signaling in a rodent model of autism. Metabolites12 (8), 720. 10.3390/metabo1208072036005593BouhtitF.NajarM.Moussa AghaD.MelkiR.NajimiM.SadkiK. (2021). New anti-leukemic effect of carvacrol and thymol combination through synergistic induction of different cell death pathways. Molecules26 (2), 410. 10.3390/molecules2602041033466806BozdagiO.TavassoliT.BuxbaumJ. D. (2013). Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay. Mol. Autism4 (1), 9. 10.1186/2040-2392-4-923621888CanA.DaoD. T.AradM.TerrillionC. E.PiantadosiS. C.GouldT. D. (2012). The mouse forced swim test. J. Visualized Experiments JoVE (59), 3638. 10.3791/363822314943CapibaribeV. C. C.Vasconcelos MallmannA. S.LopesI. S.OliveiraI. C. M.De OliveiraN. F.ChavesR. d. C. (2019). Thymol reverses depression-like behaviour and upregulates hippocampal BDNF levels in chronic corticosterone-induced depression model in female mice. J. Pharm. Pharmacol.71 (12), 1774–1783. 10.1111/jphp.1316231608449CarlezonJ. , W. A.PliakasA. M.ParowA. M.DetkeM. J.CohenB. M.RenshawP. F. (2002). Antidepressant-like effects of cytidine in the forced swim test in rats. Biol. Psychiatry51 (11), 882–889. 10.1016/s0006-3223(01)01344-012022961CastagnéV.PorsoltR. D.MoserP. (2009). Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse. Eur. Journal Pharmacology616 (1-3), 128–133. 10.1016/j.ejphar.2009.06.01819549518ChauhanA. K.BahugunaA.PaulS.KangS. C. (2017). Thymol elicits HCT-116 colorectal carcinoma cell death through induction of oxidative stress. Anti-Cancer Agents Med. Chemistry-Anti-Cancer Agents17 (14), 1942–1950. 10.2174/187152061766617032712122828356011ChenY.ChenJ.XingZ.PengC.LiD. (2024). Autophagy in neuroinflammation: a focus on epigenetic regulation. Aging Disease15 (2), 739–754. 10.14336/AD.2023.0718-137548945ChoiJ.LeeS.WonJ.JinY.HongY.HurT.-Y. (2018). Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model. PloS One13 (2), e0192925. 10.1371/journal.pone.019292529447237Cid-JofréV.MorenoM.Sotomayor-ZárateR.CruzG.RenardG. M. (2022). Modafinil administration to preadolescent rat impairs non-selective attention, frontal cortex D2 expression and mesolimbic GABA levels. Int. J. Mol. Sci.23 (12), 6602. 10.3390/ijms2312660235743046CorridoniD.PastorelliL.MattioliB.LocoveiS.IshikawaD.ArseneauK. O. (2012). Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PloS One7 (7), e42067. 10.1371/journal.pone.004206722848704CotrinaM. L.FerreirasS.SchneiderP. (2020). High prevalence of self‐reported autism spectrum disorder in the Propionic Acidemia Registry. JIMD Reports51 (1), 70–75. 10.1002/jmd2.1208332071841CrowleyT.CryanJ. F.DownerE. J.O’LearyO. F. (2016). Inhibiting neuroinflammation: the role and therapeutic potential of GABA in neuro-immune interactions. Brain, Behavior, Immunity54, 260–277. 10.1016/j.bbi.2016.02.00126851553CucinielloR.Di MeoF.FilosaS.CrispiS.BergamoP. (2023). The antioxidant effect of dietary bioactives arises from the interplay between the physiology of the host and the gut microbiota: involvement of short-chain fatty acids. Antioxidants12 (5), 1073. 10.3390/antiox1205107337237938De La ChapaJ. J.SinghaP. K.LeeD. R.GonzalesC. B. (2018). Thymol inhibits oral squamous cell carcinoma growth via mitochondria‐mediated apoptosis. J. Oral Pathology and Med.47 (7), 674–682. 10.1111/jop.1273529777637DengX.-Y.LiH.-Y.ChenJ.-J.LiR.-P.QuR.FuQ. (2015). Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice. Behav. Brain Research291, 12–19. 10.1016/j.bbr.2015.04.05225958231DesbonnetL.GarrettL.ClarkeG.BienenstockJ.DinanT. G. (2008). The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatric Research43 (2), 164–174. 10.1016/j.jpsychires.2008.03.00918456279DouX.YanD.LiuS.GaoL.ShanA. (2022). Thymol alleviates LPS-induced liver inflammation and apoptosis by inhibiting NLRP3 inflammasome activation and the AMPK-mTOR-autophagy pathway. Nutrients14 (14), 2809. 10.3390/nu1414280935889766EissaN.SadeqA.SasseA.SadekB. (2020). Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD?Front. Pharmacology11, 886. 10.3389/fphar.2020.0088632612529El-AnsaryA. (2024). “GABA and glutamate imbalance in autism and their reversal as novel Hypothesis for effective treatment strategy: an update,” in Autism. Challenges and Solutions-XII 2024. of conference.El-AnsaryA. (2016). Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief7 (7), 111–116. 10.1016/j.dib.2016.02.02526933667El-AnsaryA.Al-AyadhiL. (2014). GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J. Neuroinflammation11 (1), 189. 10.1186/s12974-014-0189-025407263El-AnsaryA. K.Ben BachaA. G.Al-AyahdiL. Y. (2011). Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Disease10 (1), 62. 10.1186/1476-511X-10-6221510882El-AnsaryA. K.BachaA. B.KotbM. (2012). Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J. Neuroinflammation9 (1), 74. 10.1186/1742-2094-9-7422531301ErbasO.ErdoganM. A.KhalilnezhadA.GürkanF. T.YiğittürkG.MeralA. (2018). Neurobehavioral effects of long-term maternal fructose intake in rat offspring. Int. J. Dev. Neurosci.69, 68–79. 10.1016/j.ijdevneu.2018.07.00130004004EsnafogluE.CırrıkS.AyyıldızS. N.ErdilA.ErtürkE. Y.DaglıA. (2017). Increased serum zonulin levels as an intestinal permeability marker in autistic subjects. J. Pediatrics188, 240–244. 10.1016/j.jpeds.2017.04.00428502607FuL.PengJ.ZhaoS.ZhangY.SuX.WangY. (2017). Lactic acid bacteria-specific induction of CD4+ Foxp3+ T cells ameliorates shrimp tropomyosin-induced allergic response in mice via suppression of mTOR signaling. Sci. Reports7 (1), 1987. 10.1038/s41598-017-02260-828512288GagoC.SerralheiroA.da Graça MiguelM. (2025). Anti-Inflammatory activity of thymol and thymol-rich essential oils: mechanisms, applications, and recent findings. Molecules30 (11), 2450. 10.3390/molecules3011245040509336GuoH.CallawayJ. B.TingJ. P. (2015). Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Medicine21 (7), 677–687. 10.1038/nm.389326121197GuoM.LiR.WangY.MaS.ZhangY.LiS. (2022). Lactobacillus plantarum ST-III modulates abnormal behavior and gut microbiota in a mouse model of autism spectrum disorder. Physiology and Behav.257, 113965. 10.1016/j.physbeh.2022.11396536126693HamamahS.AghazarianA.NazaryanA.HajnalA.CovasaM. (2022). Role of microbiota-gut-brain axis in regulating dopaminergic signaling. Biomedicines10, 436. 10.3390/biomedicines1002043635203645HanZ.KangD.JooY.LeeJ.OhG.-H.ChoiS. (2018). TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade. Exp. and Mol. Med.50 (12), 1–19. 10.1038/s12276-018-0189-830523245HeC.-W.LiaoC.-P.PanC.-L. (2018). Wnt signalling in the development of axon, dendrites and synapses. R. Soc. Open Biol.8 (10), 180116. 10.1098/rsob.18011630282660HegdekarN.SarkarC.BustosS.RitzelR. M.HanscomM.RavishankarP. (2023). Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes. Autophagy19 (7), 2026–2044. 10.1080/15548627.2023.216768936652438Herrera-BravoJ.BelénL. H.ReyesM. E.SilvaV.FuentealbaS.PazC. (2024). Thymol as adjuvant in oncology: molecular mechanisms, therapeutic potentials, and prospects for integration in cancer management. Naunyn-Schmiedeberg's Archives Pharmacol.397 (11), 8259–8284. 10.1007/s00210-024-03196-338847831HsiaoE. Y.McBrideS. W.HsienS.SharonG.HydeE. R.McCueT. (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell155 (7), 1451–1463. 10.1016/j.cell.2013.11.02424315484HughesR. N. (2004). The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci. and Biobehav. Rev.28 (5), 497–505. 10.1016/j.neubiorev.2004.06.00615465137HusseinR. M.ArafaE.-S. A.RaheemS. A.MohamedW. R. (2023). Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/Akt signaling in mice. Life Sciences314, 121256. 10.1016/j.lfs.2022.12125636549352HwangJ. W.BaekY.-M.YangK. E.YooH.-S.ChoC.-K.LeeY.-W. (2013). Lactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-κB and mTOR-mediated signaling. Integr. Cancer Therapies12 (2), 165–173. 10.1177/153473541244238022505595HwangB. J.MohamedM. A.BrašićJ. R. (2017). Molecular imaging of autism spectrum disorder. Int. Rev. Psychiatry29 (6), 530–554. 10.1080/09540261.2017.139760629231773IsaevN.ChetverikovN.StelmashookE.GenrikhsE.KhaspekovL.IllarioshkinS. (2020). Thymoquinone as a potential neuroprotector in acute and chronic forms of cerebral pathology. Biochem. Mosc.85 (2), 167–176. 10.1134/S000629792002004232093593JacksonA.ForsythC. B.ShaikhM.VoigtR. M.EngenP. A.RamirezV. (2019). Diet in Parkinson's disease: critical role for the microbiome. Front. Neurology10, 1245. 10.3389/fneur.2019.0124531920905JavedH.AzimullahS.MeeranM. N.AnsariS. A.OjhaS. (2019). Neuroprotective effects of thymol, a dietary monoterpene against dopaminergic neurodegeneration in rotenone-induced rat model of Parkinson’s disease. Int. Journal Molecular Sciences20 (7), 1538. 10.3390/ijms2007153830934738JeongJ. J.WooJ. Y.KimK. A.HanM.KimD. H. (2015). Lactobacillus pentosus var. plantarum C29 ameliorates age‐dependent memory impairment in Fischer 344 rats. Lett. Applied Microbiology60 (4), 307–314. 10.1111/lam.1239325598393Kałużna-CzaplińskaJ.BłaszczykS. (2012). The level of arabinitol in autistic children after probiotic therapy. Nutrition28 (2), 124–126. 10.1016/j.nut.2011.08.00222079796KamalmazN.BachaA. B.AlonaziM.AlbasherG.KhayyatA. I. A.El-AnsaryA. (2023). Unveiling sex-based differences in developing propionic acid-induced features in mice as a rodent model of ASD. PeerJ11, e15488. 10.7717/peerj.1548837334116KamenC. L.ZevyD. L.WardJ. M.BishnoiI. R.KavaliersM.OssenkoppK.-P. (2019). Systemic treatment with the enteric bacterial fermentation product, propionic acid, reduces acoustic startle response magnitude in rats in a dose-dependent fashion: contribution to a rodent model of ASD. Neurotox. Res.35 (2), 353–359. 10.1007/s12640-018-9960-930259417KassabR. B.El-HennamyR. E. (2017). The role of thymoquinone as a potent antioxidant in ameliorating the neurotoxic effect of sodium arsenate in female rat. Egypt. J. Basic Appl. Sci.4 (3), 160–167. 10.1016/j.ejbas.2017.07.002KawadaK.MimoriS. (2018). Implication of endoplasmic reticulum stress in autism spectrum disorder. Neurochem. Res.43 (1), 147–152. 10.1007/s11064-017-2370-128770435KerschensteinerM.GallmeierE.BehrensL.LealV. V.MisgeldT.KlinkertW. E. (1999). Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?J. Experimental Medicine189 (5), 865–870. 10.1084/jem.189.5.86510049950KhayyatA. I. A.AlabdaliA. N.AlonaziM.AlzahraniA. A.Al-ShehriE.Ben BachaA. (2025). Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism. Front. Nutr.12, 1583119. 10.3389/fnut.2025.158311940497022KhogeerA. A.AboMansourI. S.MohammedD. A. (2022). The role of genetics, epigenetics, and the environment in ASD: a mini review. Epigenomes6 (2), 15. 10.3390/epigenomes602001535735472KılıçK. D.ÇakarB.UyanıkgilY.KoenhemsiL.GüneşB.EroğluE. (2025). Therapeutic effect of bismuth subsalicylate in a propionic acid–induced autism model. Naunyn-Schmiedeberg's Archives Pharmacol., 1–12.KubotaM.FujinoJ.TeiS.TakahataK.MatsuokaK.TagaiK. (2020). Binding of dopamine D1 receptor and noradrenaline transporter in individuals with autism spectrum disorder: a PET study. Cereb. Cortex30 (12), 6458–6468. 10.1093/cercor/bhaa21132770189KumarV. (2019). Toll-like receptors in the pathogenesis of neuroinflammation. J. Neuroimmunol.332, 16–30. 10.1016/j.jneuroim.2019.03.01230928868KumarR.SharmaA.GuptaM.PadwadY.SharmaR. (2020). Cell-free culture supernatant of probiotic Lactobacillus fermentum protects against H2O2-induced premature senescence by suppressing ROS-Akt-mTOR axis in murine preadipocytes. Probiotics Antimicrobial Proteins12 (2), 563–576. 10.1007/s12602-019-09576-z31332650KuoH.-Y.LiuF.-C. (2022). Pathophysiological studies of monoaminergic neurotransmission systems in valproic acid-induced model of autism spectrum disorder. Biomedicines10 (3), 560. 10.3390/biomedicines1003056035327362KuzayD.DileközE.ÖzerÇ. (2022). Effects of thymoquinone in a rat model of reserpine-induced depression. Braz. J. Pharm. Sci.58, e19847. 10.1590/s2175-97902022e19847L'episcopoF.SerapideM. F.TiroloC.TestaN.CanigliaS.MoraleM. C. (2011). A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection. Mol. Neurodegeneration6 (1), 49. 10.1186/1750-1326-6-49LaiS.-W.ChenJ.-H.LinH.-Y.LiuY.-S.TsaiC.-F.ChangP.-C. (2018). Regulatory effects of neuroinflammatory responses through brain-derived neurotrophic factor signaling in microglial cells. Mol. Neurobiol.55 (9), 7487–7499. 10.1007/s12035-018-0933-z29427085LeberB.TripoltN.BlattlD.EderM.WascherT.PieberT. (2012). The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur. Journal Clinical Nutrition66 (10), 1110–1115. 10.1038/ejcn.2012.10322872030LiC.ZhuY.WuY.FuM.WuY.WuY. (2022). Oridonin alleviates LPS-induced depression by inhibiting NLRP3 inflammasome via activation of autophagy. Front. Med.8, 813047. 10.3389/fmed.2021.81304735096901LiloiaD.ZamfiraD. A.TanakaM.ManuelloJ.CrocettaA.KellerR. (2024). Disentangling the role of gray matter volume and concentration in autism spectrum disorder: a meta-analytic investigation of 25 years of voxel-based morphometry research. Neurosci. and Biobehav. Rev.164, 105791. 10.1016/j.neubiorev.2024.10579138960075LiuG.ChongH.-X.ChungF. Y.-L.LiY.LiongM.-T. (2020). Lactobacillus plantarum DR7 modulated bowel movement and gut microbiota associated with dopamine and serotonin pathways in stressed adults. Int. Journal Molecular Sciences21 (13), 4608. 10.3390/ijms2113460832610495LiuY.YanH.YuB.HeJ.MaoX.YuJ. (2022). Protective effects of natural antioxidants on inflammatory bowel disease: thymol and its pharmacological properties. Antioxidants11 (10), 1947. 10.3390/antiox1110194736290669LiuX.CuiJ.TanX.YuY.NiuJ.WangQ. (2025). Short-Chain fatty acids alleviate perioperative neurocognitive disorders through BDNF/PI3K/Akt pathway in middle-aged rats. Mol. Neurobiol.62, 1–16. 10.1007/s12035-025-04964-940301246LyteJ. M.GheorgheC. E.GoodsonM. S.Kelley‐LoughnaneN.DinanT. G.CryanJ. F. (2020). Gut‐brain axis serotonergic responses to acute stress exposure are microbiome‐dependent. Neurogastroenterol. and Motil.32 (11), e13881. 10.1111/nmo.1388132391630MacFabeD. F.CainN. E.BoonF.OssenkoppK.-P.CainD. P. (2011). Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav. Brain Research217 (1), 47–54. 10.1016/j.bbr.2010.10.00520937326MacFabeD. (2013). Autism: metabolism, mitochondria, and the microbiome. Glob. Advances Health Medicine2 (6), 52–66. 10.7453/gahmj.2013.08924416709MacFabeD. F.CainD. P.Rodriguez-CapoteK.FranklinA. E.HoffmanJ. E.BoonF. (2007). Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Research176 (1), 149–169. 10.1016/j.bbr.2006.07.02516950524MacFabeD. F.Rodríguez-CapoteK.HoffmanJ. E.FranklinA. E.Mohammad-AsefY.TaylorA. R. (2008). A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am. J. Biochem. Biotechnol.4 (2), 146–166.MaierS.DüppersA. L.RungeK.DackoM.LangeT.FangmeierT. (2022). Increased prefrontal GABA concentrations in adults with autism spectrum disorders. Autism Res.15 (7), 1222–1236. 10.1002/aur.274035587691MarottaR.RisoleoM. C.MessinaG.ParisiL.CarotenutoM.VetriL. (2020). The neurochemistry of autism. Brain Sciences10 (3), 163. 10.3390/brainsci1003016332182969MartinR.DalyA.DifonzoC.De La IglesiaF. (1984). Randomization of animals by computer program for toxicity studies. J. Am. Coll. Toxicol.3 (1), 1–11. 10.3109/10915818409009068MartinonF.TschoppJ. (2007). Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death and Differ.14 (1), 10–22. 10.1038/sj.cdd.440203816977329MathewS.KeerikkattilJ. (2021). Activation of cell death mediated by the crosstalk between caspase‐3 and apoptosis inducing factor in the brainstem upon exposure to monosodium glutamate and corticosterone. FASEB J.35. 10.1096/fasebj.2021.35.s1.03922MeeranM. F. N.JagadeeshG. S.SelvarajP. (2015). Thymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines. Eur. Journal Pharmacology754, 153–161. 10.1016/j.ejphar.2015.02.028MeeranM. N.JagadeeshG.SelvarajP. (2016). Thymol, a dietary monoterpene phenol abrogates mitochondrial dysfunction in β-adrenergic agonist induced myocardial infarcted rats by inhibiting oxidative stress. Chemico-Biological Interact.244, 159–168. 10.1016/j.cbi.2015.12.006MingY.DengZ.TianX.JiaY.NingM.ChengS. (2022). m6A methyltransferase METTL3 reduces hippocampal neuron apoptosis in a mouse model of autism through the MALAT1/SFRP2/Wnt/β-catenin axis. Psychiatry Investig.19 (10), 771–787. 10.30773/pi.2021.037036327957MintálK.TóthA.HormayE.KovácsA.LászlóK.BufaA. (2022). Novel probiotic treatment of autism spectrum disorder associated social behavioral symptoms in two rodent models. Sci. Reports12 (1), 5399. 10.1038/s41598-022-09350-235354898MirzaR.SharmaB. (2018). Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats. Life Sciences214, 106–117. 10.1016/j.lfs.2018.10.04530366038MohamedE. A.AhmedH. I.ZakyH. S.BadrA. M. (2021). Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer's disease. A pivotal role of NF-κB/p38MAPK/BDNF/PPAR-γ pathways. J. Ethnopharmacology267, 113468. 10.1016/j.jep.2020.11346833049345MouZ.YuanY.-h.ZhangZ.SongL.-k.ChenN.-H. (2020). Endoplasmic reticulum stress, an important factor in the development of Parkinson’s disease. Toxicol. Letters324, 20–29. 10.1016/j.toxlet.2020.01.01931987890MullerC. L.AnackerA. M.Veenstra-VanderWeeleJ. (2016). The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience321, 24–41. 10.1016/j.neuroscience.2015.11.01026577932Nagoor MeeranM. F.JavedH.Al TaeeH.AzimullahS.OjhaS. K. (2017). Pharmacological properties and molecular mechanisms of thymol: prospects for its therapeutic potential and pharmaceutical development. Front. Pharmacology8, 380. 10.3389/fphar.2017.0038028694777NakajiM.HayashiY.NinomiyaT.YanoY.YoonS.SeoY. (2002). Histological grading and staging in chronic hepatitis: its practical correlation. Pathol. International52 (11), 683–690. 10.1046/j.1440-1827.2002.01410.x12685545NankovaB. B.AgarwalR.MacFabeD. F.La GammaE. F. (2014). Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells-possible relevance to autism spectrum disorders. PLoS One9 (8), e103740. 10.1371/journal.pone.010374025170769NennigS.SchankJ. (2017). The role of NFkB in drug addiction: beyond inflammation. Alcohol Alcohol.52 (2), 172–179. 10.1093/alcalc/agw09828043969OgalyH. A.Abdel-RahmanR. F.MohamedM. A. E.OaA.-F.KhattabM. S.Abd-ElsalamR. M. (2022). Thymol ameliorated neurotoxicity and cognitive deterioration in a thioacetamide-induced hepatic encephalopathy rat model; involvement of the BDNF/CREB signaling pathway. Food and Function13 (11), 6180–6194. 10.1039/d1fo04292k35583008OjetundeA. O. (2024). The neuroprotective and therapeutic effects of medicinal plants and natural products against aluminium chloride-induced Alzheimer's Disease: recent update. Biol. Med. and Nat. Prod. Chem.13 (1), 7–33. 10.14421/biomedich.2024.131.7-33OssenkoppK.-P.FoleyK. A.GibsonJ.FudgeM. A.KavaliersM.CainD. P. (2012). Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats. Behav. Brain Res.227 (1), 134–141. 10.1016/j.bbr.2011.10.04522085877O’MahonyS. M.ClarkeG.BorreY.DinanT. G.CryanJ. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Research277, 32–48. 10.1016/j.bbr.2014.07.027ParkJ.-Y.LeeE.-H.KimJ.-E.PaengJ.-W.PaengJ.-C.KimT.-K. (2025). Lactobacillus paracasei-derived extracellular vesicles reverse molecular and behavioral deficits in mouse models of autism spectrum disorder. Exp. and Mol. Med.57, 1–16. 10.1038/s12276-025-01429-w40164687PatelC.PandeS.AcharyaS. (2020). Potentiation of anti-alzheimer activity of curcumin by probiotic Lactobacillus rhamnosus UBLR-58 against scopolamine-induced memory impairment in mice. Naunyn-Schmiedeberg's Archives Pharmacol.393 (10), 1955–1962. 10.1007/s00210-020-01904-332448977PetrelliF.PucciL.BezziP. (2016). Astrocytes and microglia and their potential link with autism spectrum disorders. Front. Cellular Neuroscience10, 21. 10.3389/fncel.2016.0002126903806PoultneyC. S.GoldbergA. P.DrapeauE.KouY.Harony-NicolasH.KajiwaraY. (2013). Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. Am. J. Hum. Genet.93 (4), 607–619. 10.1016/j.ajhg.2013.09.00124094742PutsN. A.WodkaE. L.HarrisA. D.CrocettiD.TommerdahlM.MostofskyS. H. (2017). Reduced GABA and altered somatosensory function in children with autism spectrum disorder. Autism Res.10 (4), 608–619. 10.1002/aur.169127611990QuaakI.BrounsM. R.de BorM. V. (2013). The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact. Int. Journal Environmental Research Public Health10 (8), 3384–3408. 10.3390/ijerph10083384RahiS.GuptaR.SharmaA.MehanS. (2021). Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Hum. and Exp. Toxicol.40 (11), 1880–1898. 10.1177/0960327121101345633906504RehmanM. U.GhazanfarS.Ul HaqR.UllahS.KhanS.WuJ. (2022). Probiotics (Bacillus clausii and Lactobacillus fermentum NMCC-14) ameliorate stress behavior in mice by increasing monoamine levels and mRNA expression of dopamine receptors (D1 and D2) and synaptophysin. Front. Pharmacol.13, 915595. 10.3389/fphar.2022.91559535928261RiellaK.MarinhoR.SantosJ.Pereira-FilhoR.CardosoJ.Albuquerque-JuniorR. (2012). Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodents. J. Ethnopharmacol.143 (2), 656–663. 10.1016/j.jep.2012.07.02822885071RojasD. C.SingelD.SteinmetzS.HepburnS.BrownM. S. (2014). Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. Neuroimage86, 28–34. 10.1016/j.neuroimage.2013.01.04523370056RosenfeldC. S. (2015). Microbiome disturbances and autism spectrum disorders. Drug Metabolism Dispos.43 (10), 1557–1571. 10.1124/dmd.115.06382625852213RuizL.DelgadoS.Ruas-MadiedoP.SánchezB.MargollesA. (2017). Bifidobacteria and their molecular communication with the immune system. Front. Microbiology8, 2345. 10.3389/fmicb.2017.0234529255450SaberT. M.ArishaA. H.Abo-ElmaatyA. M.AbdelgawadF. E.MetwallyM. M.SaberT. (2021). Thymol alleviates imidacloprid-induced testicular toxicity by modulating oxidative stress and expression of steroidogenesis and apoptosis-related genes in adult male rats. Ecotoxicol. Environ. Saf.221, 112435. 10.1016/j.ecoenv.2021.11243534171690SahaA.SaleemS.PaidiR. K.BiswasS. C. (2021). BH3-only proteins Puma and Beclin1 regulate autophagic death in neurons in response to Amyloid-β. Cell Death Discov.7 (1), 356. 10.1038/s41420-021-00748-x34782612SahinK.OrhanC.KaratoprakS.TuzcuM.DeehP. B. D.OzercanI. H. (2022). Therapeutic effects of a novel form of biotin on propionic acid-induced autistic features in rats. Nutrients14 (6), 1280. 10.3390/nu1406128035334937SalehiB.MishraA. P.ShuklaI.Sharifi‐RadM.ContrerasM. d. M.Segura‐CarreteroA. (2018). Thymol, thyme, and other plant sources: health and potential uses. Phytotherapy Research32 (9), 1688–1706. 10.1002/ptr.610929785774SauerA. K.StantonJ.HansS.GrabruckerA. (2021). Autism spectrum disorders: etiology and pathology. Brisbane, Australia: Exon Publications, 1–15.ScutoM.RampullaF.RealiG. M.SpanòS. M.Trovato SalinaroA.CalabreseV. (2024). Hormetic nutrition and redox regulation in gut–brain axis disorders. Antioxidants13 (4), 484. 10.3390/antiox1304048438671931ShamsS.FoleyK. A.KavaliersM.MacFabeD. F.OssenkoppK. P. (2019). Systemic treatment with the enteric bacterial metabolic product propionic acid results in reduction of social behavior in juvenile rats: contribution to a rodent model of autism spectrum disorder. Dev. Psychobiology61 (5), 688–699. 10.1002/dev.2182530689218SharifO.BolshakovV. N.RainesS.NewhamP.PerkinsN. D. (2007). Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunology8 (1), 1. 10.1186/1471-2172-8-117222336SharonG.CruzN. J.KangD.-W.GandalM. J.WangB.KimY.-M. (2019). Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell177 (6), 1600–1618. 10.1016/j.cell.2019.05.00431150625ShuC.SunL.ZhangW. (2016). Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans. Immunol. Research64 (4), 1013–1024. 10.1007/s12026-016-8785-y26783030ShultzS. R.MacFabeD. F.MartinS.JacksonJ.TaylorR.BoonF. (2009). Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long–Evans rat: further development of a rodent model of autism. Behav. Brain Research200 (1), 33–41. 10.1016/j.bbr.2008.12.02319154758SongL.PeiL.YaoS.WuY.ShangY. (2017). NLRP3 inflammasome in neurological diseases, from functions to therapies. Front. Cellular Neuroscience11, 63. 10.3389/fncel.2017.0006328337127SteruL.ChermatR.ThierryB.SimonP. (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology85 (3), 367–370. 10.1007/BF004282033923523SunandK.MohanG. K.BakshiV. (2020). Supplementation of lactobacillus probiotic strains supports gut-brain-axis and defends autistic deficits occurred by valproic acid-induced prenatal model of autism. Pharmacogn. J.12 (6s), 1658–1669. 10.5530/pj.2020.12.226SztainbergY.ZoghbiH. Y. (2016). Lessons learned from studying syndromic autism spectrum disorders. Nat. Neuroscience19 (11), 1408–1417. 10.1038/nn.442027786181Taherian-EsfahaniZ.Abedin-DoA.NouriZ.MirfakhraieR.Ghafouri-FardS.MotevaseliE. (2016). Lactobacilli differentially modulate mTOR and Wnt/β-catenin pathways in different cancer cell lines. Iran. Journal Cancer Prevention9 (3), e5369. 10.17795/ijcp-536927703648TaylorM. J.RosenqvistM. A.LarssonH.GillbergC.D’OnofrioB. M.LichtensteinP. (2020). Etiology of autism spectrum disorders and autistic traits over time. JAMA Psychiatry77 (9), 936–943. 10.1001/jamapsychiatry.2020.068032374377TeixeiraM.SouzaC.MenezesA.CarmoM.FontelesA.GurgelJ. (2013). Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats. Pharmacol. Biochem. Behav.110, 1–7. 10.1016/j.pbb.2013.05.01223714698ThapaD.RichardsonA. J.ZweifelB.WallaceR. J.GratzS. W. (2019). Genoprotective effects of essential oil compounds against oxidative and methylated DNA damage in human colon cancer cells. J. Food Science84 (7), 1979–1985. 10.1111/1750-3841.1466531206673ThomasR. H.MeekingM. M.MephamJ. R.TichenoffL.PossmayerF.LiuS. (2012). The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J. Neuroinflammation9 (1), 153. 10.1186/1742-2094-9-15322747852TiwariA.KheraR.RahiS.MehanS.MakeenH. A.KhormiY. H. (2021). Neuroprotective effect of α-mangostin in ameliorating propionic acid-induced experimental model of autism in Wistar rats. Brain Sciences11 (3), 288. 10.3390/brainsci1103028833669120UsuiN.KobayashiH.ShimadaS. (2023). Neuroinflammation and oxidative stress in the pathogenesis of autism spectrum disorder. Int. Journal Molecular Sciences24 (6), 5487. 10.3390/ijms2406548736982559VasconcelosA. S.OliveiraI. C.VidalL. T.RodriguesG. C.GutierrezS. J.Barbosa‐FilhoJ. M. (2015). Subchronic administration of riparin III induces antidepressive‐like effects and increases BDNF levels in the mouse hippocampus. Fundam. and Clinical Pharmacology29 (4), 394–403. 10.1111/fcp.1212025846646WangH.LiuQ.ZhangX. (2020). C1q/tumor necrosis factor-related protein-1 attenuates microglia autophagy and inflammatory response by regulating the Akt/mTOR pathway. Life Sciences256, 117992. 10.1016/j.lfs.2020.11799232569781WangZ.ChenH.XiongS.ChenX.GaoX.HuangP. (2025). Lactobacillus plantarum SMUM211204 exopolysaccharides have tumor-suppressive effects on colorectal cancer by regulating autophagy via the mTOR pathway. J. Agric. Food Chem.73 (10), 5931–5946. 10.1021/acs.jafc.4c0981840017402WeiC.-L.WangS.YenJ.-T.ChengY.-F.LiaoC.-L.HsuC.-C. (2019). Antidepressant-like activities of live and heat-killed Lactobacillus paracasei PS23 in chronic corticosterone-treated mice and possible mechanisms. Brain Research1711, 202–213. 10.1016/j.brainres.2019.01.02530684456WestR.RobertsE.SichelL.SichelJ. (2013). Improvements in gastrointestinal symptoms among children with autism spectrum disorder receiving the delpro® probiotic and immunomodulator formulation. J. Prob. Health.1 (1), 1–6.WuH.JiangK.YinN.MaX.ZhaoG.QiuC. (2017). Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4-and ROS-mediated NF-κB signaling pathways. Oncotarget8 (12), 20042–20055. 10.18632/oncotarget.1537328223539XieJ.HuangL.LiX.LiH.ZhouY.ZhuH. (2017). Immunological cytokine profiling identifies TNF-α as a key molecule dysregulated in autistic children. Oncotarget8 (47), 82390–82398. 10.18632/oncotarget.1932629137272XiongY.ChenJ.LvM.WangF.ZhangH.TangB. (2023). Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1/p38 MAPK pathway. Int. Immunopharmacol.117, 109885. 10.1016/j.intimp.2023.10988536842231YangJ.-w.RuJ.MaW.GaoY.LiangZ.LiuJ. (2015). BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β. Neuropeptides54, 35–46. 10.1016/j.npep.2015.08.00526311646YangY.LiN.ChenT.ZhangC.LiuL.QiY. (2019). Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway. Pharm. Biology57 (1), 625–631. 10.1080/13880209.2019.165790531545912YeX.ZhuM.CheX.WangH.LiangX.-J.WuC. (2020). Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation. J. Neuroinflammation17 (1), 18. 10.1186/s12974-019-1644-831926553YiH.HuJ.QianJ.HackamA. S. (2012). Expression of brain-derived neurotrophic factor is regulated by the Wnt signaling pathway. Neuroreport23 (3), 189–194. 10.1097/WNR.0b013e32834fab0622198686YunesR.PoluektovaE.VasilevaE.OdorskayaM.MarsovaM.KovalevG. (2020). A multi-strain potential probiotic formulation of GABA-producing Lactobacillus plantarum 90sk and Bifidobacterium adolescentis 150 with antidepressant effects. Probiotics Antimicrobial Proteins12 (3), 973–979. 10.1007/s12602-019-09601-131677091ZawadzkaA.CieślikM.AdamczykA. (2021). The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment. Int. Journal Molecular Sciences22 (21), 11516. 10.3390/ijms22211151634768946ZhangJ.ZhangJ.-X.ZhangQ.-L. (2016). PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder. Brain Res. Bull.125, 152–158. 10.1016/j.brainresbull.2016.06.00727320472ZhangW.ShiY.PengY.ZhongL.ZhuS.ZhangW. (2018). Neuron activity–induced wnt signaling up-regulates expression of brain-derived neurotrophic factor in the pain neural circuit. J. Biol. Chem.293 (40), 15641–15651. 10.1074/jbc.RA118.00284030139740ZhangH.YuanX.XiongT.WangH.JiangL. (2020). Bioremediation of co-contaminated soil with heavy metals and pesticides: influence factors, mechanisms and evaluation methods. Chem. Eng. J.398, 125657. 10.1016/j.cej.2020.125657ZhangY.LongY.YuS.LiD.YangM.GuanY. (2021). Natural volatile oils derived from herbal medicines: a promising therapy way for treating depressive disorder. Pharmacol. Research164, 105376. 10.1016/j.phrs.2020.10537633316383ZhaoC.SunL.ZhangY.ShuX.HuY.ChenD. (2024). Thymol improves ischemic brain injury by inhibiting microglia-mediated neuroinflammation. Brain Res. Bull.215, 111029. 10.1016/j.brainresbull.2024.11102939009094ZhouY.JiangZ.LuH.XuZ.TongR.ShiJ. (2019). Recent advances of natural polyphenols activators for Keap1‐Nrf2 signaling pathway. Chem. and Biodivers.16 (11), e1900400. 10.1002/cbdv.20190040031482617Glossary5-HT